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Abstract 
A diverse range of high-dimensional datasets has recently become available to help elucidate the 
functioning of biological systems and defects within those systems leading to disease. This improved 
understanding will aid our knowledge of fundamental biology as well as increasing our comprehension 
of the processes that are altered in complex disease. All of these new technologies come with the 
challenges of determining how the raw data should be efficiently processed or normalised and, 
subsequently, how can the data best be summarised for more complex downstream analysis. There are 
many approaches to summarising and normalising omics data, with new methods frequently being 
developed. Different kinds of omics data may also be integrated, in order to provide more confidence in 
predictions. To date, there has not been a comprehensive evaluation of existing methods for many omics 
data types. This thesis focusses on systematically evaluating existing methods for three different types of 
omics data and, having identified limitations in the current methods, also proposes new approaches to 
improve their quality. 
Firstly, CAGE-seq data are considered. This type of data has unique characteristics such that regional 
summarisation algorithms developed for similar experiments, such as ChIP-seq, are not directly 
applicable. Additionally, the raw data also contain artefactual measurements from confounding 
biological processes, and a comprehensive evaluation of region classification algorithms has not 
previously been carried out. A two-stage method based on a novel region-finding algorithm followed by 
a classifier that integrates sequence patterns surrounding the identified regions is shown to possess 
superior performance to two existing methods. Similarly, a novel data summarisation approach to gene 
expression data, which integrates changes in location and scale into a unified metric, demonstrates 
benefits in two-class classification problems. The error rates are found to be competitive with existing 
methods, and the feature selection has higher stability and increased biological relevance. Finally, in the 
proteomics setting, there are many choices for how to summarise peptides to proteins, as well as issues 
relating to batch effects and whether internal controls are necessary. By developing a broad variety of 
performance metrics that assess bias or variance, and an accompanying web-based framework for 
reproducible research, novel recommendations about peptide to protein summaries and batch correction 
algorithms are made, and a surprising result regarding the necessity of internal standards is revealed. 
The development and evaluation of novel dataset preprocessing approaches and the comprehensive 
evaluation of existing methods for three data types demonstrates the importance of systematic 
v 
performance evaluation of statistical bioinformatics methods for more accurate and precise knowledge 
generation in modern biology. 
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1 
Introduction 
 
Major advancements to the understanding of living systems and complex diseases enabled by new 
developments in biotechnology and statistical bioinformatics are beginning to transform modern life. 
The developments in biotechnology often provide indirect measurements of the biological entities of 
interest and have particular types of noise or bias; problems which are essential to consider for 
knowledge discovery. The associated development of new statistical methods and their evaluation in this 
and other contexts has the potential to deliver improved biological understanding and advance medicine. 
A basic introduction to the biology and biotechnology required for this thesis follows. Firstly, the key 
biological molecules that are measured and their purpose is described. Next, the technologies which are 
used to obtain the identities and quantities of the biological molecules are introduced. Thirdly, some 
challenges with evaluating statistical methods for omics data processing are highlighted. Readers 
familiar with molecular biology and the omics measurement technologies are recommended to skip to 
Section 1.3. 
1.1 Fundamentals of Molecular Biology 
Life is the continual flow of information from molecules to other types of molecules, to accomplish 
tasks such as cell growth, metabolism, and defence from disease. The major information pathway in all 
living cells is the encoding of information from deoxyribonucleic acid (DNA) sequences to ribonucleic 
acid (RNA) sequences to protein sequences and was first described over fifty years ago (Crick, 1958). 
The processing of DNA into RNA is termed transcription and the processing of RNA into protein is 
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referred to as translation. The theory left room for information to flow in the reverse direction from 
RNA to DNA, as shown in Figure 1.1, which was experimentally confirmed twelve years later by two 
research groups (Baltimore, 1970; Temin & Mizutani, 1970). 
 
Figure 1.1 The Central Dogma of Molecular Biology. The DNA in a cell exists as a pair of 
strands of nucleotides that are bonded (vertical grey lines). The sequences of nucleotides 
contain instructions for making RNA molecules. Once the information is transcribed to RNA 
form, it is usually translated into a sequence of amino acids termed a protein, although it can 
be converted back into DNA. Adapted from Fu et al. (2014, p. 294). 
 
The three categories of biological molecules are comprised of different fundamental units and have 
vastly different structures, which is why the technologies used to identify and measure them are largely 
different. 
DNA: The genome contains much of the information 
necessary for an organism to develop and live. The 
fundamental information units of DNA are the four 
bases: adenine (A), guanine (G), cytosine (C) and 
thymine (T).  Two strands of DNA are bound to each 
other with only bonds between A and T, and G and C 
being possible (Figure 1.2). Each strand has a particular 
modification at its ends and the 3’ or 5’ notation denotes the position of the modification on the sugar 
 
Figure 1.2 The DNA double helix. 
Each strand has a 5’ and a 3’ end, 
giving the two strands an antiparallel 
orientation. The two possible bonds 
are C to G and A to T Adapted from 
Becker et al. (2008, p.59). 
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ring. The segments of the DNA sequence which contain instructions for making RNA sequences are 
called genes. 
RNA: Unlike DNA, which is the same in every cell of an organism, the collection of RNA sequences 
present, called transcripts, and their abundances are different between cells and change over time. The 
first base of synthesised RNA is said to be the 5’ end of the molecule and the last base is the 3’ end. The 
first base is also referred to as the transcription start site, or TSS. It has a particular cap structure on it. 
The template strand is the strand of DNA read by the RNA polymerase. Sequences towards the 3’ end of 
the coding strand of the DNA are said to be downstream of the TSS, whereas sequences towards the 5’ 
end are said to be upstream. The region upstream of the TSS which has a regulatory function is termed 
the promoter. Segments of the newly created RNA molecule which are excised are called introns. The 
contiguous genomic regions of the sequence that remains after the introns are removed are called exons. 
Proteins: The functional entities which perform most of the tasks in a cell. Each cell is capable of 
expressing thousands of different proteins. All the proteins in an organism are referred to as the 
proteome (James, 1997). To translate a RNA sequence into a protein, the sequence is parsed in groups of 
three bases, always starting at AUG and ending at one of three base combinations. Parsing always 
occurs from the 5’ end towards the 3’ end of the RNA molecule. 
1.2 Overview of Measurement Technologies and Their Data Types 
The three types of biological molecules considered here (DNA, RNA and proteins) are comprised of 
different fundamental units and have vastly different structures. Hence, a range of experimental methods 
have been developed to measure and characterize different aspects of this system and in turn, a variety 
of complex data structures have been generated.  Understanding and efficient processing of such 
1.2 Overview of Measurement Technologies and Their Data Types 
 
4 
complex and high-dimensional data sets poses a range of challenges for modern statistics, including 
those of normalisation and summarisation. 
In this thesis, the biotechnology platforms considered are microarrays and high-throughput sequencing 
(Chapters 2 and 3), and mass spectrometry (Chapter 4). These platforms, and the type of data generated, 
are described in detail below. 
1.2.1 Microarrays 
Microarrays are a grid of regularly-spaced probes. Each probe has a particular sequence of nucleotides 
that matches to a certain genomic location; this sequence is chosen to be unique to one location in the 
genome. The molecules are first amplified and then labelled with a chemical that fluoresces. The 
abundance of each probe can be determined by the intensity of the fluorescence at a particular place in 
the grid. Each probe represents a genomic region that surrounds the probe, whose boundaries are 
determined by the lengths of the nucleic acid molecule fragments created during sample preparation. 
The value is a continuous measurement. Molecules which have some mismatches to the probe sequence 
can also bind to the probe, meaning that some probes undesirably measure a combination of different 
genomic locations (Koltai & Weingarten-Baror, 2008). This is termed cross-hybridisation. Another 
drawback is that genes which have no associated probes on the microarray, but are discovered after the 
manufacture of the microarray, are unable to be measured unless the experiment is repeated with a 
newer model of microarray. Two of the datasets used for differential distribution evaluation are 
microarray datasets (Chapter 3). 
1.2.2 High-throughput Sequencing 
In contrast to microarrays where the probes are predefined by design, high-throughput sequencing 
(HTS) determines the nucleotide sequence of tens of millions of DNA or RNA fragments, often simply 
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referred to as reads. Using a predefined database of regions of interest and counting the number of reads 
mapped within them allows estimates of abundances to be calculated. HTS has some important 
advantages over microarrays (Wang, Gerstein, & Snyder, 2009). Firstly, it can allow the discovery of 
new genomic features that are not yet found in genome databases. Secondly, microarrays have both 
background fluorescence and can reach saturation if the number of molecules of a certain sequence is 
greater than the number of probes of that sequence. For HTS, there is no background signal, and 
saturation is also not an issue. Lastly, as explained in the previous section, cross-hybridisation is a 
problem of probe-based technology, which HTS is not. One disadvantage of HTS is that it is based on 
simple random sampling of fragments, which means that some lower abundance molecules may not be 
sequenced, depending on the abundance of the most common molecules. Secondly, fragments must be 
associated with biological features of interest, such as genes or proteins. A summary of the two 
technologies is shown in Figure 1.3. HTS datasets form the basis of CAGE-seq data analysis and dataset 
integration (Chapter 2) and one of the datasets that is utilised for evaluation of differential distribution 
(Section 3.5).  
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Figure 1.3 Two Ways to Measure DNA and RNA. For RNA experiments, the molecules are 
firstly converted into DNA. Amplification of DNA is necessary to create an adequate number of 
measurable molecules. The molecules have to be broken into shorter fragments to allow them 
to be measured. Microarrays use fluorescent labelling of fragmented molecules and their 
binding to probes arrayed on a glass surface. HTS determines the sequence of the fragmented 
molecules. The count of sequences originating from a genomic region is proportional to its 
cellular abundance. This figure is hand-drawn. 
1.2.3 Mass Spectrometry-based Proteomics 
Unlike the simpler structures of DNA and RNA, proteins have more complicated 3D forms, and their 
identification and quantitation are more difficult. RNA and protein levels are sometimes not highly 
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correlated (Gry et al., 2009), because of various regulatory mechanisms that affect the rates of 
translation and protein degradation. Therefore, it is desirable to be able to accurately identify proteins 
and measure their abundances. Mass spectrometry (MS) is the most popular technique for these tasks. It 
is based on propelling protein fragments through a magnetic field in a vacuum, which separates 
fragments based on their sizes (Weickhardt, Moritz, & Grotemeyer, 1996). The size of the signal created 
by protein fragments hitting the detector is proportional to the number of those fragments in the sample. 
A more detailed background is given in Section 4.1.1. 
1.2.4 Biological Annotation of Omics Data 
Microarrays, HTS, and MS interrogate a large number of molecular sequences. By design, all 
microarray probes are annotated to known biological features. To give biological meaning to HTS- and 
MS-derived sequences, it is necessary to match the sequences to known genes or proteins. There are 
large databases of experimentally characterised genes and proteins for well-studied organisms, such as 
human or mouse. For example, RefSeq and UniProt are two such databases (NCBI 
Resource Coordinators, 2015). Many of the genes and proteins in these databases have known functions, 
which enables biologists to suggest which cellular mechanisms might be important to their topic of 
study. The computational matching is largely different for HTS and MS data. A more detailed 
background is provided in Section 2.1.5 for HTS data and Section 4.1 for MS data. 
A common challenge that is shared by various bioinformatic methods for mapping high-throughput data 
is that they need to be tolerant of minor differences between the experimental sequences and the 
database sequences. These can occur because the instrument makes an error determining the molecule’s 
sequence or because the sample under study has a genuine difference to the one found in the database, 
potentially related to the condition under study. Another challenge is the level of flexibility in handling 
ambiguity. The short sequences may match multiple locations in the genome, or multiple proteins in the 
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protein database. The software implementations of these mapping algorithms provide user-specified 
options to whether such sequences are reported, which affects summarisation of the raw data and its 
subsequent statistical analysis. Such ambiguities may bias the measurements, if ignored. 
1.3 Omics Data Methods Evaluation Challenges 
The widespread availability of complex biological data has necessitated a corresponding advancement in 
statistical methods. There exists a plethora of algorithms and methods that address issues from pre-
processing tasks, such as data summarisation and normalisation, to more complex analyses, such as 
finding enriched networks of genes in a particular condition. The issue of finding an unbiased and 
meaningful way to accurately evaluate existing and newly proposed methods remains challenging. Also, 
accuracy and precision in many settings are suboptimal and may be improved with new approaches. 
Below, three issues that are related to the challenges explored in this thesis are described. 
Absence of a Truth Set for Performance Comparison 
For a particular biotechnology, many choices of data summary and normalisation methods are available. 
Some methods have been adapted from other types of datasets, while others have been developed with 
the specific technology in mind. For example, the boundaries of signal regions derived from sequencing 
data are difficult to evaluate, because no database contains a comprehensive set of regions and, indeed, 
the regions may differ by biological condition. This has resulted in efforts where domain experts have 
been tasked with manually viewing a small subset of the data and creating a database of regions based 
on their expert judgement (Hocking, Rigaill, & Bourque, 2015). The regions selected were found to be 
highly consistent between researchers. Other region-finding evaluations have compared the DNA 
sequence within the regions to known binding patterns (Wilbanks & Facciotti, 2010). Unfortunately, 
these kinds of methods are only applicable to proteins where information on binding patterns is readily 
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available and make no assessment about the suitability of the region boundaries. Thus, there is no 
comprehensive method for region evaluation available; only reasonable approximations. 
Generalisability of Findings 
For binary classification problems, cross-validation is a common technique used for performance 
assessment. By always using different samples to train models and to make predictions with, this 
identifies which of the fitted models are stable. Feature selection stability and prediction error rate 
distribution are two types of metrics which have previously been assessed by 10-fold cross-validation 
for two classes of breast cancer (Cun & Fröhlich, 2012). Apart from selection frequency, the overlap of 
the most frequently selected features and those in known gene pathways (Mann et al., 2013), is an 
alternative evaluation of feature selection. However, this approach may understate the importance of 
genes belonging to pathways not yet characterised in public databases. Cross-validation has been shown 
to have low stability for datasets with weak signals (Martinez, Carroll, Müller, Sampson, & Chatterjee, 
2011), which motivates the use of dataset resampling with replacement together with cross-validation 
(Chapter 3). This approach gives a truer impression of classifier performance, rather than a point 
estimate. A drawback of cross-validation is that it produces better performance metrics than training and 
predicting on independent datasets (Bernau et al., 2014), a process described as cross-study validation. 
In contrast, another evaluation study found a number of examples where the error rates of traditional 
cross-validation are equivalent or better than in cross-study validation (Schramm, Campain, Scolyer, 
Yang, & Mann, 2012), suggesting that cross-validation does give realistic representations of classifier 
performance.  
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Optimal Design of Experiments 
Evaluation of preprocessing is simpler than the above two biologically-driven scenarios and is ideally 
performed with designed datasets, such as from a dilution series or spike-in design experiment. A 
dilution series design involves creating a complex mixture of the molecules under study, followed by 
manual dilution of the starting mixture to create samples with certain chosen ratios of change. The main 
difference between spike-in designs and dilution series is that a spike-in experiment is constructed with 
the same complex background mixture for every sample, but a small variety of molecules are added at 
particular amounts to each sample. Both types of studies allow the assessment of bias and variance. 
However, the absolute amounts of individual molecules cannot be controlled in dilution studies, limiting 
the number of possible comparisons. A spike-in study where each amount is present at every 
combination of two factor levels is a Latin square design (Ryan, 2007) and is utilised in Chapter 4. A 
Latin square design allows two sources of unwanted variation to be accounted for with the minimum 
number of samples. 
1.4 Thesis Outline 
The remainder of this thesis is organised as follows. Chapter 2 presents a novel two-stage approach for 
CAGE-seq region-finding and classification, followed by a case study showing its ability to find existing 
and unknown changes of potential medical importance in a prostate cancer dataset. Chapter 3 proposes a 
new summarisation approach for gene expression data with performance improvements to existing 
methods and introduces a publicly available software implementation, ClassifyR. Then, in Chapter 4, a 
set of performance metrics to characterise bias and variance are created and a range of summarisation 
and normalisation approaches are evaluated by a newly developed web-based application which allows 
users to reproduce the research findings presented and also evaluate their own methods. Finally, the key 
contributions of this research are summarised in Chapter 5.
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2 
Summarisation and 
Classification for CAGE-seq 
Data 
 
The introduction of HTS technologies provides new opportunities to characterise the mechanisms of 
disease. A broad range of applications have been developed, such sequencing of DNA to find mutations 
and copy number changes, enrichment of modified DNA and its sequencing to identify epigenetic 
deregulation, and sequencing of RNA to determine the functional regions of the genome. Capped 
Analysis of Gene Expression by sequencing (CAGE-seq) shows the diversity of transcription initiation 
across entire genomes. The identification of new transcription start sites will enable the discovery of 
new genes without any prior information and additionally may allow potential mechanisms of disease 
and development to be proposed. Two main challenges must be addressed to permit these discoveries. 
Firstly, transcripts do not precisely start in a single genomic position, but are distributed across a region. 
This creates the need for a fast and simple method of identifying transcription start regions. Secondly, 
due to biological processes other than transcription which also add 5’ caps to RNA molecules, many of 
the regions observed are not actually transcription initiation events. Classification of the 
bioinformatically identified regions is an essential filtering step in the discovery of genuine 
transcriptional initiation. The first independent evaluation of the only existing method designed for this 
task is presented, as well as another method based on integration of complementary datasets. Finally, a 
new method is developed that results in an improvement of classification performance. 
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In this chapter, a two-stage approach is described to identify the regions of true transcription initiation. 
Firstly, regions of enriched signal are identified by a fast and simple algorithm using a sliding window 
for counting read start positions and comparing to an empirical null distribution for declaring enriched 
regions. Secondly, a linear support vector machine classifier (Cortes & Vapnik, 1995), herein 
abbreviated as SVM, is utilised to distinguish between regions that represent the initiation of 
transcription and regions that do not. Evaluation of classification performance shows significantly 
improved recall and similar precision to the two existing methods. Integration of external features 
derived from different cell lines to those with CAGE-seq data had similar precision and recall rates to 
using only features derived from CAGE-seq data. The addition of matched RNA sequencing data 
resulted in minor gains in recall while maintaining a similar level of precision. 
The remainder of this chapter is organised as follows. Section 2.1 introduces CAGE-seq data and 
highlights the value of its analysis. Section 2.2 describes the new region-finding algorithm and makes 
comparisons to F-seq and Paraclu. It also explores the performance of the proposed region classifier and 
two competing methods. Having established the superior performance of the proposed region classifier, 
Section 2.3 demonstrates its use on a biological dataset of interest to determine changes in TSS regions 
between normal cells and prostate cancer cells. 
2.1 Background  
The locations of transcription start sites (TSSs) in the genome are of biological importance. There is 
rarely only a single TSS for a particular transcript (Frith et al., 2008), motivating their exhaustive 
enumeration. Clusters of TSS positions for a single transcript are referred to as TSS regions and 
frequently occur in close proximity to transcription factor binding sites (TFBS). For example, the Prkd2 
promoter contains a Gabp binding site (Yang et al., 2013). TFBS are known to regulate the packing of 
nucleosomes (Cairns, 2009), which determines the accessibility of the TSS region to the process of 
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transcription. When there is a loss of Gabp, Prkd2 expression is much reduced, and can lead to the 
development of chronic myelogenous leukaemia. Knowing the locations of the TSS regions reduces the 
genomic regions in which to search for regulatory motifs and generate hypotheses about the cause of 
changes in gene expression. Correct usage of alternative TSSs is also important for healthy development 
of the nervous system (Pruunsild, Kazantseva1, Aid, Palm, & Timmusk, 2007). This highlights the 
importance of transcription start detection to health and development. 
Biological features which have been previously associated with TSS regions provide motivation for their 
genome-wide measurement by techniques such as ChIP-seq and DNAse-seq. Also, RNA levels 
measured by RNA-seq can be informative for transcription initiation. First, a brief introduction to each 
experimental data type is given. Next, some important features of HTS mapping algorithms are 
discussed. Finally, a detailed introduction to the focus of this chapter - CAGE-seq - is provided. 
2.1.1 ChIP-seq 
For gene transcription to be initiated or paused, certain proteins - called transcription factors - can bind 
to DNA and be detached from it. Also, histones, which are proteins that are attached to DNA, can be 
modified by other enzymes attaching or removing small molecules to them. The presence or absence of 
these proteins or their modifications can allow genes to be transcribed or prevent transcription from 
occurring (Park, 2009). For instance, a modification that is commonly known as H3K4me3 has been 
associated with transcription start sites undergoing transcription (Barski et al., 2007). 
A ChIP-seq experiment designed for detecting a histone modification of interest is used for illustration. 
The experiment begins by fragmenting the chromosomes into smaller segments, followed by enrichment 
for the modification of interest (Figure 2.1). The complexes that have been enriched for are then 
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separated to keep only the DNA. Finally, the DNA is sequenced, which allows the characterisation of 
the regulatory functions of the modification. 
 
Figure 2.1 Basic steps of histone ChIP-seq. The black line is part of a chromosome. The 
grey cylinders are histones. The green circle represents a histone modification of interest. 
Firstly, the DNA is fragmented, and then only the histones that have the modification of interest 
are purified. The histones are then removed so that only the DNA remains and its sequence is 
determined. Adapted from Park (2009, p. 671). 
 
2.1.2 DNAse-seq 
Like histone modifications and transcription factors, unwound DNA has also been associated with TSSs 
that are being transcribed (Sabo et al., 2006) and can be measured using DNAse-seq. Firstly, the DNA is 
exposed to the DNAse I enzyme. The enzyme cuts the locations of unbound DNA sequence into small 
fragments, while being unable to cut sections of DNA sequence obscured by proteins (Figure 2.2). Only 
the 5’ end of the sequenced fragment is used to build up a picture of where the cutting of DNA is taking 
place. 
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Figure 2.2 Basic steps of DNAse-seq. The black line is part of a chromosome. The scissors 
are representative of DNAse I. The enzyme cuts in location that are not bound to protein, 
represented by orange and grey shapes. The resulting DNA fragments are sequenced to 
determine regions of unbound DNA. Adapted from Zentner and Henikoff (2014, p. 816). 
 
2.1.3 RNA-seq 
RNA-seq data can also provide supporting evidence for TSS regions, because transcription of a 
particular gene only occurs in one direction along a chromosome. Therefore, it is expected that there are 
significantly more sequenced fragments on one side of the TSS region than the other. RNA-seq typically 
does not directly sequence RNA molecules, but their experimentally converted DNA representations, 
termed cDNA. 
2.1.4 CAGE-seq 
CAGE-seq can answer a number of biological questions of interest. Firstly, the analysis of its data 
allows the identification of the locations in the genome where the transcription of RNA molecules is 
initiated. This enables the discovery of new genes. Secondly, when samples from different biological 
conditions are available, tests for differential expression can be done. Genes may also undergo TSS 
switching. TSS switching describes the process where the starting location of a transcribed gene 
changes, irrespective of any changes in the transcript’s abundance. Changing the locations of the TSS 
usually alters which exons are present in the transcript, which results in a different protein product being 
made (Boley et al., 2014). The first nucleotide of a transcribed RNA molecule has a five-prime cap (5’ 
cap) attached to it. RNA molecules with a 5’ cap are extracted from cells and converted into DNA for 
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sequencing, which is the first step of the experiment. Once the reads are aligned to a genome, in the 
second analysis step, only the location of the first base is considered in further analysis. The third step 
involves finding regions of signal enrichment. Finally, in the fourth step, these regions must be classified 
as TSS regions or otherwise. The entire experimental process is summarised by Figure 2.3. CAGE-seq is 
inapplicable to some biological investigations, such as mitochondrial genes, which lack the 5’ cap 
(Grohmann, Amalric, Crews, & Attardi, 1978), and bacterial genes, which have a different cap 
modification to animals (Cahová, Winz, Höfer, Nübel, & Jäschke, 2015). 
 
Figure 2.3 Key steps in the workflow for analysing CAGE-seq data. The cDNA sequences 
obtained from the sequencer (Step 1) are aligned to the reference genome (Step 2). Only the 
first position of each read is retained, and the retained positions are clustered into regions 
(Step 3). Lastly, a classification algorithm is used to label the regions as being from 
transcription initiation or not (Step 4). The focus of this study is on steps 3 and 4. 
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CAGE-seq signal regions may be broad or narrow and they only appear on one strand, unlike ChIP-seq, 
so the development of specific region-finding methods to this datatype is necessary. Also, a caveat of 
CAGE-seq is that it detects all 5’ RNA caps, even those not related to the transcription process (Otsuka, 
Kedersha, & Schoenberg, 2009; Mercer et al., 2010). Despite this major problem being known for many 
years, research publications using CAGE-seq data continue to overlook this issue (Kratz et al., 2014; 
Hashimoto et al., 2015). 
Challenges for Region-finding 
Various existing methods are available for the task of finding regions. The earliest method groups reads 
into regions if they overlap by at least one base (Carninci et al., 2006). This is likely to join positions 
that are thousands of bases away for highly expressed transcripts, which causes signals from different 
genes to be incorrectly merged into single regions. It also lacks any statistical basis. A later approach, 
using the Maximal Scoring Subsequences algorithm (Frith et al., 2008), is implemented in the software 
package Paraclu and relies on exhaustively using all possible values of a penalty parameter for the width 
of a candidate region. This alters the breakpoints of regions to obtain all regions possibly supported by 
the data. The sheer number of results it returns, many of which overlap multiple known genes, means 
that it requires manual post-processing to arrive at a sensible number of regions. A minor modification 
of Paraclu, called RECLU, has recently been published (Ohmiya et al., 2014). It reports the widest and 
narrowest regions, instead of all regions, but still requires time-consuming user intervention to arrive at 
a final set of regions. The other difference to Paraclu is that the number of reads per million reads for 
each genomic position is used, to allow the method to produce comparable results between samples 
which have a different number of total sequences. These minor modifications mean that RECLU retains 
most of the drawbacks of Paraclu. One major limitation is that the algorithm does not work without 
replicates, which is a common scenario for CAGE-seq datasets. A third approach is based on looking for 
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adjoining positions with CAGE reads that have constant relative expression across multiple samples 
(Balwierz et al., 2009). Unlike the previously mentioned methods, this approach uses rigorous statistical 
methods for parameter estimation and hypothesis testing. However, this method also requires sample 
replicates. In contrast, F-seq is an approach that doesn’t require replicates and involves fitting a kernel 
density estimates (KDE) around each genomic location with non-zero read count (Boyle, Guinney, 
Crawford, & Furey, 2008). It has been applied to numerous DNAse I datasets, but never for CAGE-seq 
data, motivating its evaluation in the present study. The method chooses regions of signal based on a 
threshold found by calculation of KDEs on a randomisation of the genomic positions of the reads. 
Challenges for Region Classification 
The results of the aforementioned region-finding algorithms depend on read density, and do not classify 
regions as originating from transcription initiation or confounding biological processes, despite the 
importance of this. The only algorithm specifically designed to classify CAGE regions is based on 
modelling nucleotide k-mer frequencies surrounding the regions using an unsupervised hidden Markov 
model (Djebali et al., 2012), herein called the ENCODE HMM method. Two models are trained. In the 
first, the k-mers used in training are weighted proportionally to the number of reads in a region. In the 
second model, all k-mers are weighted equally. The posterior probability of each cluster fitting to the 
main model is calculated using Bayes’ rule and regions are classified using a threshold on the 
probability. In other words, the algorithm biases towards learning the features of CAGE regions with 
high read counts, and against regions derived from lowly expressed genes. No validation of results from 
the classifier was performed in the original article. The authors also did not consider integrating external 
data in their model, which could potentially improve the classifier’s performance. Segway is another 
method that classifies regions into categories, such as TSS, Enhancer, and Gene End, but does not take 
CAGE-seq data as input (Hoffman et al., 2012). It is based on dynamic Bayesian networks. The simplest 
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approach that avoids region classification (and region calling) altogether is to make small counting 
windows around annotated TSS (Plessy et al., 2012), before performing an analysis of the amount of 
signal, such as differential expression. The drawback is that novel transcription starts, and even novel 
genes, are ignored. 
In summary, the CAGE-seq algorithms proposed previously do not sufficiently model features of the 
dataset to enable accurate region determination and their classification. The region-finding algorithms 
either overestimate the size of regions by not properly taking into account the noise distribution or 
provide millions of mostly overlapping and redundant regions. Also, the region classification algorithms 
have not been independently evaluated, which may identify possibilities for improvement. 
2.1.5 HTS Mapping 
Millions of short sequences obtained from the sequencing technologies introduced above must be 
accurately mapped to a large reference genome in a reasonable amount of time. The large number of 
reads generated and the size of genomes has motivated the development of fast and accurate algorithms 
for short sequence mapping. Unlike the classic Needleman-Wunsch algorithm for aligning pairs of 
sequences, the algorithms developed for HTS data use heuristics to find good matches, but don’t 
guarantee finding the best match of a sequence to a reference. The earliest of these is Bowtie 
(Langmead, Trapnell, Pop, & Salzberg, 2009), which uses a Burrows-Wheeler transform and a 
Ferragina-Manzini index to align about 25 million sequences per hour. Bowtie is sufficient for mapping 
CAGE-seq, ChIP-seq, and DNAse-seq data. Most RNA-seq data has special requirements for its 
accurate mapping. RNA-seq mapping software needs to be able to map sequences across large gaps, 
because of introns. Specialised applications for mapping RNA sequences to the genome include TopHat 
(Trapnell, Pachter, & Salzberg, 2009) and STAR (Dobin et al., 2013), which use similarly efficient data 
structures and heuristics to Bowtie to map millions of reads in a short amount of time. 
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2.2 Two-stage Preprocessing Algorithm 
To enable biologically valid insights to be derived from CAGE-seq data, a two-stage approach is 
proposed. In the first stage, a sliding widow is applied across the genome and regions are identified 
based on comparison to a large number of randomly chosen regions. In the second stage, a linear SVM 
is applied to predict if the found regions are caused by transcription initiation or biological artefacts. 
2.2.1 Region-Finding 
In the first stage, a sliding window approach is used to detect regions of significant signal enrichment 
using a cut-off based on randomly sampled windows. The algorithm starts with background estimation, 
followed by window joining and region trimming. Assuming that genuine TSS signals are rare in the 
genome, 1000 candidate windows of width w are generated at random locations in the genome. The 
CAGE reads within each window are counted and the 95th percentile of the counts is taken as the cut-off 
value, below which a window is deemed to have insufficient signal to form a region. Next, a candidate 
window of width w is moved along each strand of each chromosome in increments of 𝑤/2. Here, 𝑤 =
50 is used, which is typical of regions found previously (Carninci et al., 2006). For each candidate 
window, the count of CAGE read starts is made. If the count is above the background cut-off value, the 
window is added to a list of regional windows. The ends of regional windows are trimmed for 
outermost, contiguous positions that contain counts less than the cut-off value, divided by the window 
width. Finally, any adjacent regional windows separated by less than 30 base pairs are merged into a 
single region. 
2.2.1.1 Comparison of Regions 
Evaluation is based on publicly available CAGE-seq data of six cell lines (GM12878, H1-hESC, K562, 
HeLa-S3, HepG2, and HUVEC – the CAGE cell lines). Mapped BAM files were downloaded from the 
ENCODE data repository (ENCODE Project at UCSC, n.d.) on the UCSC Genome Browser website. 
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Preprocessing details are found elsewhere (Djebali et al., 2012). The unique Submission IDs are 3946, 
2380, 2359, 2363, 2381, and 2376 and the number of mapped reads are 19677397, 24604761, 24319886, 
24394908, 24604043, and 18717719, respectively. 
All three algorithms discover tens or hundreds of thousands of regions in each sample (Table 2). The 
proposed method finds the least number of regions for each cell line. The greatest number of regions are 
found for the H1-hESC cell line by the proposed method, but HepG2 for the other two methods. H1-
hESC is the only stem cell sample in the study; the other five are differentiated cells. F-seq finds over 
one million regions for GM12878 and HepG2 cells. 
Table 2.1 Number of regions detected for each cell line. The proposed sliding window, 
Paraclu and F-seq are evaluated. 
 
 
 
 
 
Tabulation of the overlaps of regions between the proposed method with the regions found by Paraclu 
and F-seq demonstrates that there is a lot of similarity between the regions found by the methods 
evaluated (Table 2.2). Indeed, every region found by the proposed method is also found by Paraclu. 
However, a visual exploration of the regions shows that Paraclu and F-seq are detecting many other 
regions which have minimum support – as little as one CAGE-seq read (Figure A-1) – or they span large 
regions of the genome, which contain multiple known genes. 
 Region-finding Method 
Cell Line Proposed  Paraclu F-seq 
GM12878 83729 391522 1011954 
H1-ESC 266462 359810 695536 
HeLa-S3 78719 394452 798761 
HepG2 117421 410276 1104620 
HUVEC 76107 406642 816312 
K562 68692 367558 764056 
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Table 2.2 Percentage overlap between proposed method’s regions and those found by 
Paraclu and F-seq. Regions must have at least one base overlap and be on the same 
genomic strand to be considered as overlapping. 
 
 
  
  
 
2.2.2 Classification of Regions 
A linear support vector machine (SVM) classifier is developed to classify regions found by the proposed 
method as TSS or otherwise with high precision and recall. Two kinds of features are calculated for each 
region; internal features and external features. Internal features are those that may be computed from 
the CAGE-seq data directly or the genome it is mapped to. External features are derived from associated 
datasets, such as ChIP-seq or RNA-seq. External features may be further divided into matched and 
pooled features. Matched features are those that are calculated on the same sample the CAGE-seq is 
performed on, whereas pooled features are those calculated from an aggregation of other samples 
distinct from the sample under consideration. Many features are computed in windows that are a certain 
distance upstream and downstream of the region’s summit. Definitions of these terms are provided in 
Section 1.1. 
2.2.2.1 Features and Classes 
Three internal features are considered: 
Kurtosis: Pearson’s kurtosis of the CAGE read histogram of an identified region, based on the fourth 
standardised moment, is calculated. This feature is analysed to examine if any differences in shape 
would be discriminatory. 
 Region-finding Method 
Cell Line Paraclu F-seq 
GM12878 99.7% 100% 
H1-ESC 99.8% 100% 
HeLa-S3 99.7% 100% 
HepG2 99.8% 100% 
HUVEC 99.7% 100% 
K562 99.7% 100% 
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Read density: The number of CAGE reads inside the boundaries of an identified region, divided by the 
width of the region. This feature is a combination of the shape and height of a region. 
4-mer counts: Patterns of DNA bases surrounding the TSSs are also known to be different to other 
regions in the genome (Sonnenburg, Zien, & Rätsch, 2006). A 500 base pair window was created 
upstream and another downstream of the summit of each CAGE region. Frequencies of all 4-mers were 
calculated independently for the two windows. In the upstream window, there are 44 = 256 distinct 4-
mers, and similarly downstream, making a total of 512 4-mer features. 
Furthermore, five external features are considered. All datasets were downloaded from the ENCODE 
Project Repository (ENCODE Project at UCSC, n.d.). 
Mammalian conservation: Considered for its known association with regulatory regions, such as 
promoters, scores within the regions are used. For each region, the conservation values of each base are 
averaged. A small fraction of regions may not overlap with any bases with conservation scores, because 
the genomic sequence is not able to be multiply aligned to the other genomes. For these regions, an 
imputed value, equal to the minimum value of regions that had available conservation scores, is used. 
TFBS: For each region, the maximum score in a window extending 100 base pairs from the region 
boundaries is assigned to the region. Rather than exclude cell type-specific signals, the measured 
maximum is used. Pooled measurements of transcription factor binding from 95 cell types of an 
unspecified number of transcription factors stored in the table wgEncodeRegTfbsClusteredV2. 
DNAse I hypersensitivity: This feature is considered because TSSs typically occur in open chromatin.  
Similar to TFBS, the maximum count within 100 base pairs from region boundaries is determined. 
Pooled DNAse I hypersensitivity data using 74 cell lines was obtained from the table named 
wgEncodeRegDnaseClustered. 
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H3K4me3:  This histone modification is known to be found on the nucleosomes surrounding active 
TSSs. Again, the maximum score within 100 base pairs of the region boundaries is calculated. Seven 
files were downloaded with Submission IDs of 2806, 2815, 2846, 2878, 2890, 2909, and 2921. 
RNA-seq difference: The number of RNA-seq reads on either side of the region is counted. One count is 
a 100 base wide flanking window immediately upstream of the 5’ edge of the region. The other is the 
same size, but downstream of the 3’ edge of the region.  The feature calculated is 𝑃(𝑌 ≤ 𝑦) of the 
Poisson distribution where 𝜆 is equal to the downstream flank count and y is the count in the upstream 
flank. Unmapped, total RNA-seq data for two of the six CAGE cell lines (GM12878 and K562) was 
downloaded. Total RNA-seq data is not available for the other four cell lines. The unique Submission 
IDs are 1502 and 1503. Raw reads were mapped to the human genome assembly hg19 with STAR 
(Dobin et al., 2013). Only uniquely mapping reads and no more than 3 mismatches to the reference 
sequence were allowed. 40 bases from the ends of each pair of reads were ignored, as these correspond 
to stretches of low-quality sequencing data. No splice junctions spanning more than 100000 bases were 
allowed. 
All features are standardised to be between 0 and 1 by dividing by the maximum score for all regions, 
per feature type and per cell line. A concise overview of all features is provided by Table 2.3. 
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Table 2.3 Features considered for TSS classification. For each feature, the summarisation 
procedure, location of data points summarised, and the feature categorisation are shown. 
 
Name Summarisation Location Type 
Kurtosis Directly used Region Internal 
Read Density Directly used Region Internal 
4-mers Counts Count 500 bases upstream  
and downstream of region summit 
Internal 
TFBS Maximum Region and 100 base extension of 
boundaries 
External Pooled 
DNAse I 
Hypersensitivity 
Maximum Region and 100 base extension of 
boundaries 
External Pooled 
H3K4me3 
Hypersensitivity 
Maximum Region and 100 base extension of 
boundaries 
External Pooled 
Mammalian  
Conservation 
Average Region External Pooled 
RNA-seq Difference Distribution function 
probability 
100 bases flanks adjacent 
to region boundaries 
External Matched 
      
 
The class labels of regions determined by ENCODE HMM were also obtained from the repository, with 
Submission IDs 5610 and 5147. Five of the cell lines erroneously have the same submission identifier in 
the database, although manual inspection confirmed that all files do contain sample-specific results. 
Segway’s labels were downloaded from the supplementary materials website accompanying ENCODE’s 
analysis of the same six cell lines (Hoffman et al., 2013). 
2.2.2.2 Classifier Construction 
Unlike typical classification datasets, where the true class membership is known in advance, TSS 
datasets require the assignment of inferred class labels to regions. Class labelling of regions was made 
by the same method used for Segway’s evaluation (Hoffman et al., 2012); Segway is, to date, the most 
comprehensive study of TSS region determination. It involves the use of dynamic Bayesian networks to 
create a segmentation of the genome, followed by manual assignment of biological categories to the 
segments by a domain expert. Briefly, 500 bases wide windows were made upstream and downstream of 
2.2 Two-stage Preprocessing Algorithm 
 
26 
the start position of each GENCODE transcript. If a detected region overlapped with any of the 
windows, it was labelled as a TSS region. Otherwise, it was assigned to the non-TSS class. 
PCA (Mardia, Kent, & Bibby, 1979) on the labelled TSS regions was used to select features for the 
classifier. Firstly, the six scalar features of kurtosis, read density, TFBS, DNAse I hypersensitivity, 
H3K4me3 hypersensitivity, and mammalian conservation were used (Figure A-2). The first dimension 
had visible separation between the two classes. Features with an absolute correlation to PC1 of more 
than 0.5 were used in the model. The features selected were: average mammalian sequence conservation 
(𝜌 =  −0.85), DNase I hypersensitivity maximum (𝜌 =  −0.74), TFBS maximum (𝜌 =  −0.90), and 
H3K4me3 maximum (𝜌 =  −0.88). In addition to the scalar features, the vector feature of 4-mer 
frequency was also evaluated. PCA was used on standardised counts of the 512 distinct 4-mers (Figure 
A-3). The first principal component had noticeable separation of the two classes. There were 148 4-mers 
that had |𝜌| ≥ 0.5 with PC1, and used subsequently in classification. 
Classifier training is performed using the selected features with a L2-regularised L2-loss linear SVM in 
a leave-one-out cross-validation (LOOCV) scheme, using primal solving. In the primal form, there are 
as many variables (parameters which define the decision boundary of the classifier) to optimise as there 
are features, which is an efficient model training approach in this scenario. To handle imbalanced class 
sizes, error weights are provided for each class. Not adjusting for differences in set sizes of the smaller 
TSS and larger non-TSS set would result in high accuracy for the non-TSS set and low accuracy for the 
TSS set, since the default parameterisation of SVMs is to maximise the overall number of correct 
predictions (Akbani, Kwek, & Japkowicz, 2004). For the TSS class, the weight is calculated as the 
number of peaks in the non-TSS class divided by the number of peaks belonging to the TSS class. For 
the non-TSS class, the weight was 1. 
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2.2.2.3 Classification Performance Evaluation 
Classification performance is evaluated on the metrics of precision and recall. Precision is the fraction of 
TSS-classified regions that are labelled as TSS regions. Recall is the fraction of labelled TSS regions 
that are classified as TSS regions by the linear SVM. 
A broad range of cost values was evaluated, to understand classification performance at different 
hardness levels of the SVM margin (Figure A-4). The classification procedure was reasonably robust to 
the cost value used and a cost of 0.1 is used in the following evaluations. 
Three classification scenarios are considered: 
Internal features only: This involves using only the selected 4-mers. 
Internal and pooled external features: The selected 4-mers and the four previously-selected features 
derived from the public datasets are used. 
Internal and matched external features: The selected 4-mers and RNA-seq counts are considered. 
Considering classification with internal features, the proposed method has high precision and recall for 
all cross-validations (Table 2.3). The performance metrics obtained using the proposed SVM classifier 
are compared to those obtained by two other algorithms; Segway and ENCODE HMM. Details of 
Segway and ENCODE HMM algorithms are provided in Section 2.1.4. ENCODE HMM has the highest 
recall for all samples, however this is always accompanied by low precision. The method is biased to 
producing false positive predictions. Segway has a good balance between precision and recall, although 
the recall is, on average, 0.19 less than the proposed method’s recall. The addition of pooled external 
features has no systematic benefit to precision or recall (Table A-1). The use of the matched external 
feature derived from RNA-seq data shows a minor gain in recall and also an increase in precision of 
0.13 for the H1-ESC sample.  
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Table 2.4 Precision and recall values for the internal features LOOCV classification. For 
each cell line, classifier training was performed on the five other cell lines. A cost parameter of 
0.1 is used for the linear SVM classifier. 
 Segway 
  
ENCODE HMM 
  
Proposed Method 
  Cell Line Precision Recall Precision Recall Precision Recall 
GM12878 0.70 0.64 0.25 0.92 0.77 0.81 
H1-ESC 0.59 0.71 0.27 0.89 0.61 0.81 
HeLa-S3 0.79 0.66 0.32 0.91 0.76 0.87 
HepG2 0.59 0.59 0.23 0.93 0.69 0.79 
HUVEC 0.82 0.67 0.26 0.94 0.81 0.85 
K562 0.77 0.62 0.27 0.93 0.71 0.88 
 
2.3 Case Study: Prostate Cancer 
The proposed two-stage method is applied to a dataset consisting of one healthy prostate cell line (PrEC) 
and one cancerous prostate cell line (LNCaP) sample (Bert et al., 2013). A number of TSS regions with 
high-ranking changes in read counts for genes never previously associated with prostate cancer are 
found. Using version 17 of the GENCODE human gene database (Harrow et al., 2012), it is possible to 
annotate TSS regions to known genes and evaluate how well-known in the prostate cancer research field 
the differentially expressed genes are using the GeneValorization text mining tool (Brancotte et al., 
2011). 
Regions have been called using the algorithm described in Section 2.2.1 for each sample. 42445 regions 
were found for the PrEC sample and 31707 for the LNCaP sample. 29927 regions were classified as 
TSS regions for PrEC and 22585 for LNCaP. Regions which had any overlap between the two 
conditions were merged by calculating the union of regions’ genomic coordinates. This resulted in 
38923 distinct regions used for further evaluation. A linear SVM using only the selected 4-mers’ counts 
and trained on the six ENCODE cell lines was applied to the prostate cancer dataset to predict each 
region’s class. GFOLD (Feng et al., 2012) was used to produce a ranking of shrunken (generalised) fold 
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changes, because no statistical analysis of differential expression is possible in this unreplicated dataset. 
The shrinkage applies more strongly to genes with low read counts, preventing the rankings from being 
biased towards genes which have a relatively small numerator and denominator in their fold change, 
which often result in large, but unstable, fold changes. The 100 regions which have the largest absolute 
GFOLDs were overlapped with known genes and 98 have a match to a gene. The gene with the best 
associated GFOLD statistic has clear differences between conditions in a plot of the count data (Figure 
A-5A). 88 distinct genes were text mined with GeneValorization for the term “prostate cancer” and a 
large spread of journal publications per gene was found. The gene EREG has been associated with 
prostate cancer in 20134 publications. The median number of publications per gene is eight. Seventeen 
of the 98 genes have never been associated with prostate cancer before. 
Differential TSS usage evaluation finds even more changes in prostate cancer of biological interest. 
Genes which have at least two associated TSS regions are considered. There are 3119 such genes. A 
Fisher’s exact test is not used because of the lengthy computation time required. Instead, a TSS 
switching statistic for a gene is defined as the difference between the largest and smallest fold changes, 
on the log2 scale, multiplied by the minimum of the average counts of the minimum or maximum fold 
change regions. Visual representation of the top ranked gene, DUT, illustrates that the proposed TSS 
switching method is choosing appropriate genes (Figure A-5B). GeneValorization text mining analysis 
of the top 100 genes shows that only a few of these genes have been previously associated with prostate 
cancer. The median value is 0 publications, while the maximum value, for gene ATPIF1, is 1451 
publications. 
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2.4 Discussion and Conclusion 
A novel two-stage approach comprised of a fast and simple region-finding method, followed by a linear 
SVM classifier has been developed to detect thousands of regions per sample and categorise whether 
they are TSS regions or not. This study is also the first time that F-seq has been evaluated with CAGE-
seq data. Three dataset scenarios were assessed to determine if data integration can provide an 
improvement in precision and recall. Finally, the new approach was used on a prostate cancer dataset. 
Many previously known gene-disease associations were rediscovered, as well as a number of novel 
genes that warrant further biological investigation. 
Although F-seq reliably found the boundaries of regions, it produced an excessively long list for the 
dataset analysed. Closer inspection of the results found that many genomic locations with only one 
CAGE read mapping to them were identified as regions. A possible reason for this is that F-seq takes the 
reads and randomises their position along the genome to find a cut-off value. In contrast, the proposed 
method keeps the locations of the original data values, but generates random windows and counts the 
number of reads within them. The null model used by the proposed method may be more appropriate for 
CAGE-seq data than the model used by F-seq. 
It may initially be surprising that neither kurtosis nor read density were strongly associated with the first 
principal component of the PCA plot in Figure A-2, which was associated with region class. However, 
previous research on CAGE-seq region properties provides support for this disparity. CAGE regions 
have been able to be categorised into three different shapes; broad, sharp, and multi-modal (Carninci et 
al., 2006). All of these shape categories have many regions which belong to the promoter regions of 
known genes, providing support for the idea that TSS regions have a broad range of read densities and 
kurtoses. The selection of 4-mer features for their association with region classes also agrees with 
previous research work (Sonnenburg, Zien, and Rätsch 2006). 
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Evaluation of integrating pooled external features showed there was no overall benefit to incorporating 
freely available datasets with CAGE-seq data. When an orthogonal dataset on the same sample was 
available, such as RNA-seq, there were minor gains in recall, while precision improved for one of the 
cell lines. In a practical setting, this suggests that integrating RNA-seq data should be done if it is 
already available, but it is not worth the effort of generating RNA-seq data for the sole purpose of 
integrating it with CAGE-seq data. No firm conclusions can be drawn about the effect of integrating 
matched RNA-seq data, however, because only two out of six samples have such data available. 
A limitation is the lack of a truth set independent of any experimental data used by this study. It was 
necessary to generate the truth set by using the CAGE reads and the GENCODE gene annotation, as the 
authors of Segway did in their study. This potentially introduces an unwanted biases into the evaluation 
procedure. One such possible bias is for biologically real TSS regions missed by the CAGE technique 
being labelled as not being TSS regions in the truth set. This would lead to false negatives being counted 
as true negatives. Also, the GENCODE gene annotation, like any biological database, is sure to be 
incomplete. The cells being studied in the experiment may have real TSS regions which are not stored in 
the database. This leads to true positives incorrectly being counted as false positives. Lastly, the 
accuracy of the TSS positions in the GENCODE database is impossible to quantify. The database does 
not provide experimental evidence or a confidence score for its entries. When evaluating precision and 
recall, it is necessary to assume that most of the TSS positions are correct. The future development of a 
robust and independent truth set is important for the accuracy of any CAGE-seq evaluation study. 
Another limitation is the lack of biological replicates available for each cell type, ruling out any formal 
hypothesis testing. It is desirable to evaluate whether the regions and their classifications are stable in a 
scenario where multiple replicates of each biological condition are available. 
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In summary, an effective two-stage algorithm comprising of a sliding window region-finding method 
and linear SVM classifier have been developed to accurately identify and classify CAGE-seq read 
regions. The algorithm has been compared to existing published methods and both the region-finding 
and classification stages demonstrated superior performance to existing methods.
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3 
Differential Distribution for 
Binary Classification Problems 
 
In the last decade, technologies such as microarrays and high-throughput sequencing have enabled the 
simultaneous measurement of expression for tens of thousands of genes, which allows the hypothesis-
free discovery of novel associations with disease, also known as biomarkers. Biomarkers routinely 
become the basis of patient care and disease classification. To date, a central theme in disease 
classification using omics data is using the change in average expression, often referred to as differential 
expression (DE), as the main measure of differences between classes of samples. For the task of survival 
class prediction, the error rate remains undesirably high and the stability of selected features for the 
classifier has not been characterised (Jayawardana et al., 2015). Recent studies have shown that when 
transcription factors or epigenetic signals become deregulated, a change in expression variability (DV) 
of target genes is frequently observed (Ho, Stefani, dos Remedios, & Charleston, 2008; Hulse & Cai, 
2013). However, assessing the importance of genes by either differential expression or variability alone 
potentially misses sets of important biomarkers. Integrating both types of changes could lead to 
improved prediction and prognosis for patients. 
A new approach is described here for assessing the importance of genes based on differential 
distribution (DD), which combines information from differential expression and differential variability 
into a unified metric. A comprehensive simulation study is carried out, to pick a representative method 
for DV and DD. The proposed statistic based on the differences of medians and absolute deviations is 
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found to choose a broad variety of features and a naïve Bayes kernel voting method is shown to have 
low classification error. Based on findings in the simulation study, a direct comparison between 
representative feature selection methods for the three types of distributional change is carried out on 
three cancer datasets. Feature ranking and selection stability based on differential distribution is shown 
to perform two to three times better than DE or DV alone, and also yield equivalent error rates to DE 
and DV. Finally, assessing genes via differential distribution produces a complementary set of selected 
genes to DE and DV, potentially opening up new categories of biomarkers. A novel classification 
execution and evaluation framework, ClassifyR, is implemented in R and used to carry out all 
evaluations in a fast and reproducible way. 
The rest of this chapter is structured as follows. In Section 3.1, overviews of existing classifiers for 
omics data based on either DE or DV data features, and corresponding classification frameworks in R 
are provided. Section 3.2 outlines the procedures for feature selection, training, and prediction for the 
three change types evaluated. Section 3.3 defines the metrics used to compare competing methods. 
Section 3.4 provides a comparison of two varieties of DV selection and four varieties of DD selection 
using two novel and two existing varieties of the naïve Bayes classifier. The best-performing selection 
method for each change type is used in an evaluation of classifier performance on three biological 
datasets in Section 3.5. Section 3.6 introduces ClassifyR, a software which has been developed for 
parallelised classification and its comprehensive evaluation.  Finally, the benefits of DD classification 
and opportunities for its improvement are summarised and discussed in Section 3.7. 
3.1 Background 
Accurate prediction of patient survival has the opportunity to optimise patient treatment. Those patients 
who have genetic features associated with lengthy survival can avoid treatment and its associated 
problems. Avoiding unnecessary treatment reduces costs to the healthcare system and also allows 
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clinicians to focus their efforts on patients who need immediate intervention. One of the earliest studies 
built a classifier for different subtypes of leukaemia with different severities, based on finding a set of 
genes that are uniformly high in one class and low in the other (Golub et al., 1999). Since then, a wide 
range of studies have been used to determine important biomarkers (features), with applications such as 
predicting survival outcomes (Eschrich et al., 2005; Jayawardana et al., 2015), disease subtypes (Mills et 
al., 2009; Marisa et al., 2013), drug sensitivity (Gunther, Stone, Gerwien, Bento, & Heyes, 2003; L. Li et 
al., 2014), and even behavioural characteristics (Takahashi et al., 2010). Apart from RNA expression, 
many studies have utilised other kinds of biological platforms, such as proteins (Li et al., 2013) and 
metabolites (Kim, Koo, Jung, Chung, & Lee, 2010). Reviews of classification methods based on 
differences in average expression levels can be found elsewhere (Ferté et al., 2013; Lin & Chen, 2013; 
Domany, 2014). 
Recently, variances of expression (differential variability) have been found to differ in numerous gene 
expression datasets (Ho et al., 2008; Hulse & Cai, 2013). One biological interpretation for this is that 
increased variability of the RNA level of a particular gene, caused by the loss of precise regulation of its 
expression, may follow disruption of transcription factors or epigenetic signals by pathogenic processes, 
leading to greater variation of the expression level between samples within the affected class 
(Haraksingh & Snyder, 2013). The study by Ho and his colleagues found that highly variable genes are 
highly co-expressed with many more genes than are genes with lower variability in their expression, 
suggesting an increase of regulation in networks of genes. Genes with higher variability are typically 
associated with the disease state, although high variability per se may be evolutionarily conserved 
between species and serve a potentially beneficial purpose in some gene systems (Mostafavi et al., 
2014). 
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Motivated by these biological insights, two main statistical approaches have been developed to assess 
the association of genes with disease phenotypes, such as prognosis. In the earliest proposal, mixture 
models, which can also measure differential expression, were developed (Bar, Booth, & Wells, 2014). 
Another method, diffVar (Phipson & Oshlack, 2014), based on testing absolute deviations from class 
means in a linear modelling framework, is limited to discovering changes in variability. Despite these 
methods showing the ability to find genes with differential variability between conditions, neither study 
developed a corresponding metric for feature selection or investigated its potential as a biomarker in a 
classification setting. 
The potential of differential variability to aid in classification was recently demonstrated for the first 
time in a comprehensive study of DNA methylation in a number of cervical cancer datasets 
(Teschendorff & Widschwendter, 2012). A differential variability classifier based on adaptive index 
models (Tian & Tibshirani, 2011) outperformed a differential methylation classifier for predicting early-
stage cancer, although there was no difference in classification performance of later stages. This 
suggests that traditional DE classifiers disregard important differences which are present in biological 
datasets. 
Differential variability attempts to use the characteristics of deregulated networks to provide a new 
approach to assessing the importance of genes. However, it omits useful information from changes in 
locations between classes. To address this, a novel metric is proposed, based on identifying genes with 
differential distribution to enable simultaneously identifying genes that are differentially expressed, 
differentially variable, or both. As such, DD aims to avoid the need for ad-hoc DE and DV classifier 
aggregation algorithms, such as taking the intersection of selected features, by detecting features with 
both kinds of changes using the same metric and requiring only one classification algorithm, rather than 
two. Biologically, a change in distribution, such as from unimodality to multimodality, suggests that a 
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gene has an expression range which must be maintained for healthy cellular function. Increases in 
variability can be similarly interpreted. Furthermore, we extend such feature selection criteria into a 
classification setting. 
To date, no research literature has examined DD classification for biological problems. In other fields, 
such as engineering, DD classification by a multidimensional kernel density estimate predictor has been 
shown to perform slightly better than methods like LDA (Ghosh, Chaudhuri, & Sengupta, 2006) on a 
simulated dataset and low-dimensional datasets from physics and chemistry, motivating its exploration 
in high-dimensional omics datasets. This demonstrates the need to develop and evaluate an alternative 
set of DD metrics as a type of discrimination measure for identifying candidate genes of interest as well 
as using those metrics in a novel classification scheme applied to high-dimensional datasets. DV and DD 
are, for the first time, characterised in terms of model stability, something which is known to be lacking 
for DE feature selection (Cun & Fröhlich, 2012). Additionally, the performance of all three 
classification schemes is systematically examined based on their prognostic error rates and biological 
relevance. 
Existing Classification Software 
Although a large collection of disparate classification software packages exist in R, there are no 
available frameworks for linking existing or custom classification functions with a comprehensive set of 
classification performance measures. An effective classification package should exhibit the 
characteristics of fast computational time, reproducible results (e.g. random number seed, storing 
algorithm parameters used), flexibility to incorporate user-defined classification functions and post-
processing options for performance assessment. There are some R packages which provide only a subset 
of these desirable features. For example, SPRINT (Mitchell et al., 2014) provides a new framework for 
parallelizing classification algorithms in R, but requires new classification functions to be coded in C or 
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Fortran. This is challenging for users who are only proficient in R. Many popular R packages, such as 
e1071 (Meyer et al., 2014) and PamR (Hastie, Tibshirani, Narasimhan, & Chu, 2013), provide a small 
number of classifiers but are not extensible. caret is a popular framework which provides 
parallelization and customisable classifiers, but lacks post-processing evaluation functions (Kuhn, 
2008). Similar packages, such as MLInterfaces, CMA and MCRestimate are also available from 
Bioconductor, but are also not comprehensive classification solutions. A new framework to integrate 
classification and performance evaluation is required. 
3.2 Feature Selection and Classification 
The particular feature selection methods and classifier utilised are distinct for each type of change. 
DE: The process differs for microarrays and RNA-seq datasets. (a) For microarray data, genes are 
ranked on their moderated t-statistics using the implementation in limma (Smyth, 2004). Training and 
prediction for the microarray datasets is performed using diagonal linear discriminant analysis (DLDA), 
originally developed for classification of cancer samples based on their gene expression measurements 
(Dudoit, Fridlyand, & Speed, 2002). (b) For RNA-seq data, genes are ranked based on a likelihood ratio 
test statistic of negative binomial generalised linear models using the implementation in edgeR 
(Robinson, McCarthy, & Smyth, 2010). Poisson linear discriminant analysis (PLDA) is used to 
determine a decision boundary and make predictions, as it has been demonstrated that DLDA finds 
suboptimal decision boundaries for count data, whereas PLDA finds the correct boundary (Witten, 
2011). A power transformation was applied to eliminate overdispersion, making PLDA applicable to 
RNA-seq count data. 
DV:  For microarray data, the normalised values were directly used. For RNA-seq data, the mean-
variance trend was removed by using the regularised logarithm transformation of DESeq2 (Love, Huber, 
3.2 Feature Selection and Classification 
 
39 
& Anders, 2014), to avoid detecting DV features simply caused by DE. Features were then ranked based 
on either their Bartlett or Levene statistic and selection was applied. The Bartlett test (Bartlett, 1937) 
tends to choose features with a small number of outliers, whereas the Levene statistic (Levene, 1960) is 
robust to outliers. Before training and prediction, feature values were calculated as the absolute value of 
the difference of each measurement with the median of all samples in the training set and taking the 
absolute value. Thus, if the values originally came from a normal distribution the transformed values 
will follow a half-normal distribution. Fisher’s linear discriminant analysis (FLDA) was used for 
classification. 
DD: Four approaches for assessing the differences between two different distributions (class 1 and class 
2) are considered. These are the differences of medians and deviations, the Kolmogorov-Smirnov 
distance, the log-likelihood ratio, and simply combining the results of individual DE and DV selections. 
Motivated by the success of finding DE genes by considering the absolute differences in medians for the 
melanoma dataset (Jayawardana et al., 2015), the Differences of Medians and Deviations (DMD) is 
defined as: 
DMD = |𝑚𝑒𝑑𝑖𝑎𝑛1 − 𝑚𝑒𝑑𝑖𝑎𝑛2| + |𝑄𝑛1 − 𝑄𝑛2| 
where 𝑚𝑒𝑑𝑖𝑎𝑛1 and 𝑚𝑒𝑑𝑖𝑎𝑛2 represent the median expression values of class 1 and 2, respectively. 
The values 𝑄𝑛1 and 𝑄𝑛2 represent the robust scale estimator (Rousseeuw & Croux, 1993) for class 1 and 
2, respectively. The Kolmogorov-Smirnov (KS) distance is simply defined as the greatest distance 
between the empirical cumulative distribution functions of the two classes. Thirdly, a log-likelihood 
ratio statistic with robust estimates of the location and scale was used: 
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where subscript 𝑖 denotes membership of class 𝑖, 𝑠𝑖 denotes the number of samples in class 𝑖 and 𝑓 is the 
probability density function of the normal distribution. The LLR is the log of the likelihood ratio statistic 
for testing whether the two classes come from the same normal distribution or two different normal 
distributions where robust estimators of the mean and standard deviation are used in place of the 
maximum likelihood estimators. Terms without subscripts use values from samples in both classes. 
Finally, ensemble feature selection was performed by combining the selections which use the moderated 
t-test from limma and Bartlett test by taking the union of selected features. This is a naïve way to 
jointly capture features that are changing means and also those that are changing variances. 
For each of the chosen features, a kernel density estimate is built for each of the two classes using a 
Gaussian smoothing kernel and bandwidth calculated by Silverman’s rule, which are the default settings 
of the density function in R. For the RNA-seq dataset, counts were transformed by the regularised 
log method, to prevent feature selection being biased towards differentially expressed genes, because of 
overdispersion of count data. To predict a sample from the test set, a naïve Bayes classifier is used for 
each feature. Two types of the classifier are considered. Firstly, each feature votes once for the class that 
has the maximum a posteriori estimate and the class with the largest number of votes is the predicted 
class. This is referred to as unweighted voting. Also, the differences between class densities, the 
distances from the observation to the nearest non-zero crossover point of the two densities, and the sums 
of those two weights are calculated and summed over all selected features, with the sign of the sum 
determining the class prediction. This is termed weighted voting. Intuitively, the crossover distance 
3.2 Feature Selection and Classification 
 
41 
weighting captures how far away a measurement is from the nearest substantial observation of the class 
with lower density at the measurement point. 
To summarise the voting schemes, let + and – denote the two classes that a sample can belong to. Let 𝑛+ 
and 𝑛− represent the number of samples in the training set belonging to each class. Let 𝑑+ and 𝑑− 
represent the fitted densities of each class. Let g be the vector of measurements of a selected gene 
chosen in the feature selection stage. sgn is the sign function. Unweighted voting can be 
mathematically expressed as: 
mode(foreach 𝑔𝑖 in g (sgn(𝑛+ × 𝑑+(𝑔𝑖) −  𝑛− × 𝑑−(𝑔𝑖)))) 
Weighted voting has the form: 
sgn(sum(foreach 𝑔𝑖 in g (𝑛+ × 𝑑+(𝑔𝑖) −  𝑛− × 𝑑−(𝑔𝑖)))) 
A summary of the various feature characteristics and classifiers for them is presented in Figure 3.1. 
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Figure 3.1 Summary of feature types and classifiers. For each of differential expression, 
differential variability, and differential distribution, a representative gene expression distribution 
is shown, along with an illustration of the classification process. In the left column, the dashed 
vertical lines represent the means of the class distributions. In the right column, the variables 𝑥 
and 𝑦 denote two different genes in a dataset. Each point indicates a sample. The bottom right 
panel illustrates that each gene from the selected gene set votes independently in differential 
distribution classification. The black circle shows the position along the x-axis of the expression 
measurement value. The intervals show two kinds of distance weighting evaluated in the 
simulation study. The green interval corresponds to crossover distance voting and the black 
interval to height difference voting. 
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All classifications in this chapter have the same basic structure. 100 variations of each dataset were 
created by resampling with replacement followed by 5-fold cross-validation, to obtain the distribution of 
metrics. The reasons for doing so are described in Section 1.3. For each iteration of cross-validation: 
1. The training data is first processed by a feature selection function. In each case, the feature 
selection function chooses the set of features by testing each gene individually, ranking them by 
a score, and calculating resubstitution error rates for the top 𝑥 ranked features. Values of 𝑥 
considered ranged from 10 to 150, in increments of 10. The value of x  which obtains the lowest 
balanced error rate determines the size of the set of top features selected. 
Let 𝑇 be the set of samples in the training set. Let ?̂?(𝑡) be a classifier function which predicts the 
class of sample 𝑡 and let 𝐶(𝑡) be a function that returns the known class of sample 𝑡. Then, the 
resubstitution error rate is defined by the expression: 
1
𝑛
∑ I𝑇𝑅𝑈𝐸(?̂?(𝑡)  ≠  𝐶(𝑡) )
𝑡∈𝑇
 
I is an indicator function. 
2. For only the proposed DV classification, a transformation of expression values is made. For each 
feature, all samples’ expression levels are subtracted from the median expression level of the 
training set, and absolute values taken. This transforms the data into a form which allows a 
classifier that uses linear decision boundaries to be applied. 
3. The samples assigned to the training set in the current iteration are used for model building. 
4. The samples assigned to the test set in the current iteration have their classes predicted. 
The choice of using the resubstitution error for feature selection is a pragmatic one. Ideally, a nested 
cross-validation would be used. However, this approach is computationally infeasible in practice. 
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3.3 Evaluation Metrics 
Feature ranking stability is assessed by considering the feature rankings of every cross-validation 
iteration of a particular classification. The top 𝑡 ranked features are considered for each iteration, and 
every possible pair-wise intersection of feature identifiers is done. The average size of the intersections 
is converted to a percentage by dividing by 𝑡. A range of values between 10 and 100 were assessed. To 
assess feature selection stability, overlap percentages between all pairs of selected feature sets were 
calculated as:  
𝑜𝑣𝑒𝑟𝑙𝑎𝑝𝑖,𝑗 =
|𝑓𝑒𝑎𝑡𝑢𝑟𝑒𝑠𝑖 ∩  𝑓𝑒𝑎𝑡𝑢𝑟𝑒𝑠𝑗|
|𝑓𝑒𝑎𝑡𝑢𝑟𝑒𝑠𝑖 ∪  𝑓𝑒𝑎𝑡𝑢𝑟𝑒𝑠𝑗|
× 100 
The indices 𝑖 and 𝑗 are for different iterations of the cross-validation loop of a particular classification. 
Feature ranking commonality and feature selection commonality are similarly defined, except that the 
feature set comparison is between two kinds of classification, rather than within a classification. 
Balanced error rate is the main performance measure considered, and can be thought of as the average 
error rate for the two classes, denoted positive and negative. This is defined as 
𝐵𝐸𝑅 =  
𝐹𝑃
𝑃 +
𝐹𝑁
𝑁
2
 
where FP denotes the number of false positives and P denotes the number of samples in the positive 
class. Similarly, FN and N represent the number of false negative and N the number of samples in the 
negative class. It may be significantly different to ordinary error rates in situations where there is a 
major class imbalance. 
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3.4 Simulation Evaluation of DV and DD Varieties 
Evaluation of the Bartlett test and Levene test for feature selection has not been carried out before, DV 
classification has not been characterised in a simulation study, and DD selection and classification 
methods have never been applied to high-dimensional data, motivating their characterisation. 
Each simulated dataset was created by first taking the melanoma dataset used for biological dataset 
evaluation (Section 3.5) and filtering out any genes showing any differences between classes to create a 
background set. Then, a subset of genes in the background set were altered to create specific kinds of 
signals. The detailed steps are: 
1) Background expression: To define features with differences between classes, six methods were used 
to rank features of the melanoma dataset in terms of DE, DV, and DD, from largest statistic to smallest. 
These were based on moderated t-statistic, a Bartlett statistic, a Levene statistic, a DMD distance, a KS 
test statistic, and a likelihood ratio statistic. Features that appeared in the top 20% of any of the six lists 
were excluded from the unchanged feature set. This gave 9453 unchanged features and 300 of these 
features were randomly chosen to be changed to create seven simulated datasets. 
2) Changed Features: Each of the seven created datasets has varying proportions of changed features. 
These are DE, DV, differentially skewed (DS) and differentially modal (DM) features. For each dataset, 
the changing features and their magnitudes were chosen by randomly choosing a class and a direction of 
change, with both the classes and directions being equally likely. To add noise for DE features, 10% to 
30% of randomly chosen samples in the unchanged class were also changed by the same amount. The 
random sampling of change magnitude was repeated for each feature. The same set of features which 
were altered for the changed class were altered for the samples belonging to unchanging class. 
Additionally, 
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(a) The amount of change for DE features was sampled from a log-normal distribution with 
mean 1 and standard deviation 1. The change was applied by adding or subtracting the change 
value from the measurements. 
(b) Two varieties of DV features were simulated; consistent and outlier. Each variety was 
equally as likely to be applied to a feature. 
Consistent: For a particular feature, the standard deviation of the chosen samples was 
increased or decreased by a number sampled from a log-normal distribution with mean 1 
and standard deviation 1. This enlarges or shrinks the spread of data symmetrically. 
Lastly, the values were shifted to keep the original mean. 
Outlier: Between 10% and 30% of samples in a randomly chosen class had their 
expression values increased or decreased by an amount sampled from a Uniform(2, 5) 
distribution. This simulates another observed pattern of DV in biological datasets. 
(c) For DS features, the median expression value of the change class was calculated and either 
the values lower or higher than this value chosen to be changed. The change to be added or 
subtracted came from independent samples from a log-normal distribution with mean 1 and 
standard deviation 1. The change value was multiplied by the distance of each sample on the 
changing side from the median, before being added to median, to calculate the new value of the 
changed samples. 
(d) DM features were created by calculating the mean of the change class and sampling two 
mean changes from a log-normal distribution with mean 1 and standard deviation 1. One change 
is the distance to the simulated lower mode’s mean and the other is the distance to the simulated 
higher mode’s mean. Additionally, two standard deviation values were sampled from a log-
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normal distribution with mean 1 and standard deviation 
1
2
. Once the changed means and standard 
deviations were found, random samples (of the same number originally above and below the 
median value) were drawn from the normal distribution with the mean and standard deviation of 
each mode. This creates a bimodal distribution. 
Both DV feature selection methods select an undesirably large proportion of features from the 
background feature set; typically about 50% of selections (Figure 3.2A). As expected, features simulated 
as DE are rarely selected. DV features comprise almost all of the features that are selected. DM features 
are chosen in similar proportions to their presence in each simulated dataset The classifier which uses 
the Bartlett statistic for feature selection has a consistently better median BER than the classifier which 
performs feature selection using the Levene statistic. (Figure 3.2B). The BERs are higher for datasets in 
which the simulated DV proportion is smaller. Therefore, feature selection based on the Bartlett statistic 
is used for biological dataset classification evaluation. 
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Figure 3.2 Feature selection proportions and balanced error rates of DV classification for 
seven simulated datasets. A. Proportions of selected genes. The average percentage of 
selected genes that are in the specified simulated change categories over all cross-validations 
is shown. The bottom row shows the proportions of simulated changes. B. Balanced error 
rates of class predictions. The distributions of error rates across all cross-validation iterations 
are shown as boxplots. 
 
Varieties of DD classification (Section 3.2) were examined that incorporate different choices of how 
distance between classes is measured to compare weighted and unweighted voting schemes. DD 
classification is found to perform well across a range of possible simulation settings. Firstly, it was 
examined whether the four different selection approaches select differing proportions of simulated 
changed features. The features chosen by DMD mirror the pattern of simulated changes most closely 
(Figure 3.3A). The KS statistic selects no DV features for most simulations. Regardless of how common 
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they are, it favours the selection of features that are simulated to be DE. The likelihood ratio selection 
chooses features in proportions similar to which they were simulated in, but always chooses more 
unchanged features than the DMD method. About half of the features chosen are those which are 
simulated to be unchanged. In terms of BER (Figure 3.3B), the DMD selection statistic with weighted 
classification using the crossover distance has the lowest error rate for most of the simulated datasets. 
Likelihood ratio and ensemble selection have quite variable balanced error rates between datasets, 
particularly for the height and sum of differences weightings. Because it selects features in the desired 
proportions and has good error rates across all seven datasets, the DMD statistic combined with 
crossover distance weighted voting is used for biological dataset classification evaluation. 
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Figure 3.3 Feature selection 
proportions and balanced 
error rates of DD 
classification for seven 
simulated datasets. A. 
Proportions of selected genes. 
The average percentage of 
selected genes that are in the 
specified simulated change 
categories over all cross-
validations is shown. The fifth 
row shows the proportions of 
simulated changes. B. Balanced 
error rates of class predictions. 
The distributions of error rates 
across all cross-validation 
iterations are shown as 
boxplots. 
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3.5  Evaluation of DE, DV, and DD 
Three experimental datasets are used for comparison of selection and classification performance. All 
values from microarrays were transformed to the log
2
 scale. Cases in each dataset were partitioned into a 
good prognosis class and a poor prognosis class. An external database (MalaCards) was obtained for 
evaluation of feature selection in terms of previously disease-associated genes. 
Melanoma: The raw microarray expression and clinical data are available from GEO as GSE54467. The 
samples were assayed on the Illumina Human WG-6 BeadChip microarray, version 3. Previously 
defined classes for this dataset (Jayawardana et al., 2015) of poor prognosis as death less than one year 
from metastasis (n = 22) and good prognosis as survival of more than four years with no signs of 
recurrence (n = 25) are considered. Raw data was NEQC normalised (Shi, Oshlack, & Smyth, 2010) and 
probes which had less than ten samples with a detection p-value of < 0.01 were removed from further 
analysis. The detection p-value is calculated by the microarray scanner’s control software and gives the 
probability that the gene is not expressed. This leaves 17699 probes to use for classification. 
Serous Ovarian Cancer: Processed microarray data generated by the study GSE13876 were obtained 
from the Bioconductor package curatedOvarianData (Ganzfried et al., 2013). Gene expression 
was measured with Operon Human (version 3) microarrays developed by the Netherlands Cancer 
Institute. 20577 genes are measured in this study. Poor prognosis is defined as death within two years (n 
= 22) and good prognosis as survival of five or more years (n = 25). 
Lung Adenocarcinoma: The processed data was obtained from TCGA Data Portal (The Cancer Genome 
Atlas - Data Portal, n.d.) on 16 May 2014. Poor prognosis cases were defined as those who died less 
than one year from diagnosis and good prognosis cases as those who lived for over four years, with no 
signs of recurrence. This resulted in a total of 18 poor prognosis and 18 good prognosis samples. 
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Sequencing was performed on an Illumina HiSeq 2000 instrument. Normalised gene count values were 
used. Genes that had fewer than ten counts in less than ten samples were removed from further 
consideration. This left 16321 genes for use in classification. 
The follow-up time densities using all samples from each dataset show that the TCGA lung cancer 
dataset has relatively few cases with long follow-up times, while the other two datasets have a greater 
variety of follow-up times (Figure B-1). 
MalaCards: Cards for melanoma, ovarian cancer, and lung cancer were downloaded from the MalaCards 
website (http://www.malacards.org) on 25 March 2014. These are gene lists for particular diseases with 
scores for each gene proportional to that gene’s association to the disease in the published literature (26). 
In the ovarian cancer dataset, some features were annotated with multiple alternative gene names. For 
those genes, the maximum MalaCard score of matching names was chosen. 
DE, DV, and DD classification all display a similar error profile for all three cancers. Figure 3.4A shows 
the balanced error rates for all three datasets classified by all three types of classification. For melanoma, 
the median balanced error rate for the resampling and folding validation is 23%, 26% and 24% for DE, 
DV, and DD, respectively. A similar pattern is observable for the other two cancers. Ovarian cancer is 
the most difficult to classify in all cases whereas lung cancer has the lowest median error rate for each 
classification type. The spread of the BER values is large. For example, each of the BER distributions 
has values as low as 5% or as high as 50%, depending on the iteration of the cross-validation. By 
chance, it would be expected to obtain BERs of 50%, so all three classifications almost always perform 
much better than classification at random. 
The error rates of individual patients are also similar between methods. That is, some samples are 
systematically classified poorly for all three gene assessment types, while others are typically classified 
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correctly. The percentage of misclassifications of every sample was calculated for each method and 
plotted as an error map (Figure 3.4B). Darker shading indicates correct predictions are made in more 
cross-validations. For example, melanoma patient TB52 is classified poorly by all three methods, 
whereas TB36 is always classified well. There are more misclassified samples in the smaller class for 
ovarian cancer. The lung cancer dataset has balanced class sizes and no tendency in misclassification is 
observed.  
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Figure 3.4 Cross-validation balanced error rates and sample-wise error rates. A. 
Distribution of balanced error rates over all iterations of cross-validation. B. Sample-wise error 
rates. Each patient is one column of a heatmap. Each classification type is one row of a 
heatmap. Details of the selection and classifier algorithms are provided in the Methods section. 
The error rates are binned into five equally sized bins. Colour scales are shaded by class 
colour, with a darker colour indicating less frequent misclassification than a lighter colour. 
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The genes selected are largely different for each of the three selection types. Considering all the samples 
for each dataset, the top DD-ranked 50 genes ranked have only minor overlaps with both DE- and DV-
ranked genes (Figure 3.5A). Ovarian cancer has the smallest overlaps between methods, with only one 
gene in common between possible pair of selections. For the ovarian cancer and lung cancer datasets, 
one gene is common to all three selection types. Regardless of the dataset considered, all pairwise 
overlaps between selection types are 12% or less of the size of the set union. 
The selected features also have little overlap (Figure 3.5B). For melanoma and lung cancer, only one 
feature is chosen by all three assessment types. For melanoma and lung cancer, the DE and DV 
selections have just one gene in common. There are no common genes between DE and DV selection for 
ovarian cancer. The size of the gene list chosen also varies widely from dataset to dataset. DE selection 
gives the most compact sets, ranging from 10 to 30 features. DD selection for lung cancer gives the 
biggest set of features, choosing all 150 that were considered. It also chooses 110 features for the 
melanoma dataset, while the other two methods choose 10 or 20 features. 
Although these sets of genes had little overlap, the DD-selected genes are enriched for those of 
biological significance (Figure 3.5C). Considering the top-ranked genes, DD selection provides the most 
disease-associated genes for the melanoma and ovarian cancer datasets over different subsets of top-
ranked genes. For lung cancer, it selects almost as many high-scoring genes as DE. DV selection 
provides the lowest cumulative score of previously disease-associated genes for every dataset. The low 
recall of DV is clearest for the lung cancer dataset, where the cumulative sum plateaus at top rankings 
no higher than 50. The top-ranking DV features of ovarian cancer are almost entirely unassociated with 
the disease. 
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Figure 3.5 Feature ranking and selection overlaps. A. Overlaps between three feature 
selection types for three cancer datasets. The 50 highest-ranked genes of each method are 
used. All samples are used. B. Overlaps between three feature selection approaches for three 
cancer datasets. The genes selected by best resubstitution error rate of each method are 
used. All samples are used. C. Cumulative MalaCards scores for the most frequently selected 
features in cross-validation. 
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In cross-validation using the cancer datasets, differential distribution selection yields more features in 
common over all pairs of cross-validations. Considering the highest ranking genes, the DD-selected 
features are typically two to three to times more stably ranked than DE features, depending on the 
dataset (Figure 3.6A). For lung cancer, the stability is as much as six times higher. DD feature ranking is 
also more stable than DV feature ranking for the ovarian and lung cancer datasets. The lung cancer 
dataset benefits the most from DD selection, with stabilities ranging between 30 and 35 percent. The 
lung cancer dataset has the highest selection stability overall, whereas the ovarian cancer dataset 
achieves the lowest. 
Feature selection based on differential distribution is also the most stable (Figure 3.6B). The DD median 
selection score is about twice as large as the second highest median score, except for melanoma, where 
it is nearly identical to DV’s score. For the ovarian and lung cancers, the second highest median score is 
from DV selection. The median selection score of DE selection is the lowest in every dataset. The 
interquartile range for DD scores is the largest, except for melanoma, where DV has a slightly larger 
spread. The expression distribution of the most frequently selected feature in each dataset and of each 
feature type is illustrated (Figure B-2). The most stable genes for ovarian cancer have much less 
noticeable differences between survival classes than the most stable genes for the other two cancers. 
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Figure 3.6 Cross-validation feature ranking and selection stability. For each pair of 
comparisons, the number of genes in common is divided by the number of genes in the union 
and converted to a percentage. A. The average pairwise overlap of the top ranked genes is 
calculated for all iterations of cross-validation. Shapes represent datasets and colours 
represent different types of classification. B. The distribution of the pairwise overlaps of the 
selected genes is calculated for all iterations of cross-validation. From left to right, the number 
of data points which are greater than 20% and are not shown as points is: 475, 16879, 5301, 
305, 593, 5884, 963, 2489, and 29384. 
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3.6 ClassifyR Classification Evaluation Framework 
All of the previous results were generated with ClassifyR, a customisable framework for classification 
and its evaluation (Strbenac, Mann, Ormerod, & Yang, 2015). ClassifyR has been assessed and accepted 
into the Bioconductor project. It is publicly available for download at 
http://www.bioconductor.org/packages/release/bioc/html/ClassifyR.html. A tutorial with runnable code 
based on a public benchmarking dataset is also available from the same webpage. The framework is 
implemented as four modular components. The data transformation stage takes a matrix of data and 
returns a matrix of transformed data. This stage is optional. The feature selection stage takes a matrix of 
training data and returns a vector of indices indicating which features were selected and a ranking of all 
features. Training uses the training samples and the selected features to build a classifier. Finally, the 
prediction stage takes a matrix of test data and returns a vector of class predictions. The order that stages 
are executed in is user-defined, which allows some unusual classifiers, such as nearest shrunken 
centroids (Tibshirani, Hastie, Narasimhan, & Chu, 2003), to work with the framework. Nearest shrunken 
centroids is unusual in that it requires classifier training before feature selection. All of the feature 
selection and classification algorithms evaluated in previous sections have defined functions in the 
package, as well as some classifiers not used in this study, such as the nearest shrunken centroids 
classifier and fitting of mixtures of normals followed by posterior probability class prediction. If the user 
doesn’t provide any specification of feature selection and training parameters, by default, a limma 
moderated t-test is done and a DLDA classifier is used to perform 100 resamples and 5-fold cross-
validation. 
Three varieties of cross-validation are available to the user through the function runTests. 𝑟 
resamples and 𝑘-fold involves resampling the samples which comprise the dataset with replacement 𝑟 
times. Similarly, 𝑟 resample and 𝑠% split resamples the samples with replacement, but it splits the newly 
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created datasets such that 𝑠% of randomly chosen samples form the training set and 100 − 𝑠% of 
samples form the test set. In other words, unlike the 𝑟 resamples and 𝑘-fold scheme, not all samples in 
each resampled dataset are used for prediction. Thirdly, leave-k-out uses all combinations of k samples 
from the dataset as the test set and the remainder of the samples as the test set. Values of 1 or 2 are 
typically used, as larger values of k are computationally intractable. Each iteration of cross-validation is 
independent from all others. Therefore, cross-validation is implemented to easily run on multiple 
processor cores. Classifications of the melanoma dataset demonstrate that the time savings of using 
multiple cores are substantial (Table B-1). Apart from cross-validation, the situation of independent 
training and test sets is handled by the function runTest. In fact, the cross-validation functionality 
available from runTests involves repeated use of runTest for each iteration of cross-validation. 
Virtually any feature selection method or classifier can be used with ClassifyR. This is enabled by a 
formalisation of what parameters each of the four stages requires (Table B-2). Also, the function which 
processes each stage has rules about the order of variables passed into it (Section B.2). Many 
classification functions available from other R packages already coincidentally conform to these rules. 
However, even those functions which do not can easily be used by writing a short wrapper function 
around them. An example of a wrapper for the 𝑘 nearest neighbours classifier from the R package 
class is shown in Section B.2. A number of wrappers are provided by ClassifyR, such as the 
classifyInterface function which wraps the PLDA implementation in the package PoiClaClu. 
Feature selection and class prediction may be easily evaluated by a number of convenience functions. 
These evaluate feature ranking and selection stability, feature ranking and selection commonality 
between classifiers, sample-wise error rate, cross-validation error rate, receiver operating characteristic 
curves (for classifiers with a continuous predictor), and calculation of over 20 performance metrics (e.g. 
Matthews Correlation Coefficient, F1 score). Details are available in the software documentation. All of 
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these evaluation functions takes as input the direct output of the classification procedure or a list of such 
outputs. Classification evaluation is streamlined and reproducible by this style of implementation. 
3.7 Discussion and Conclusion 
Stable and accurate prediction of sample classes from gene expression signatures or other kinds of omics 
datasets remains a challenging problem in cancer prognosis and omics research. Previous research 
(Phipson & Oshlack, 2014), as well as this study, has found that DE and DV methods select mostly 
different sets of genes. Feature selection using all samples in a dataset had a minimal overlap, ranging 
from 1% to 5% for the cancers considered. These large differences in selected sets motivated the 
development of measures that seamlessly combine the characteristics of both DE and DV methods. 
Here, a kernel density-based DD measure has been developed with a corresponding prognostic 
algorithm and evaluation done to demonstrate that it performs well in terms of classification and 
stability on both simulated and three sets of high-dimensional transcriptome datasets. 
Feature selection stability is an important problem, because if a feature is selected infrequently in a 
resampling procedure, that feature may have been selected by chance and not related to the outcome of 
interest, which limits its translational potential. The sources of selection instability have been previously 
characterised and ensemble feature selection proposed as a solution (Yang et al. 2013). This, however, is 
computationally costly, as it requires the training of many similar models. Also, the combining of 
features from different models is subjective, and depends on a user-specified parameter of how many 
models the feature should be selected in to be used in the final model. In comparison, differential 
distribution selection by the DMD method has been shown to always be more stable than the popular 
moderated t-statistic and equally or more stable than the Bartlett statistic, without requiring the 
generation of multiple models and subjectively aggregating them. As shown by Figure 3.5C, for each 
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dataset, the DMD selection type chose more genes in common with MalaCards than DE or DV in two 
out of three datasets, suggesting that DD has more power than either of the alternatives. 
Assessment of genes via DV remains a potentially desirable type of classification when one seeks to 
classify samples using mostly experimentally-unexplored genes. The top ranked DV genes for each 
dataset had the least overlap with currently well-known disease-associated genes, as defined by 
MalaCards (Figure 3.5C). Although this observation may seem concerning at first, it is actually expected 
and can be explained by publication bias. Almost all prior research work on biomarkers has focussed on 
obtaining markers that have a systematic change in expression between conditions. Only one study has 
attempted classification with differential variability (Teschendorff & Widschwendter, 2012) and the lack 
of variability-associated disease genes in public databases is likely to end, once more studies begin to 
consider DV or DD classification. 
Figure 3.4 shows that ovarian cancer had a higher BER than the other two datasets for all three 
classification types, as well as more patients with high patient-specific error rates. The difficulty of 
ovarian cancer survival prediction has been demonstrated recently (Lisowska et al., 2014). The lowest 
FDR value obtained from fitting a Cox regression model to each gene was 0.85. Selecting the four best 
genes simply based on odds ratio magnitudes and testing them on an independent dataset found that 
none of them were transferrable to an independent dataset. 
Considering Figure 3.4B, it is evident that error rates for a minority of patients were very high when 
assessing genes via DE, DV or DD. Although most patients in each class were classified correctly at 
least 80% of the time, a small number of patients were classified incorrectly in the majority of cross-
validations. The frequent incorrect classification happened regardless of the type of classification done. 
This could be as a result of differences in medical treatment or other unspecified confounding factors. 
For example, two patients could each have a gene signature that is associated with poor prognosis, but 
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one patient may have received better surgical treatment than the other and, therefore, survive a long 
time. Therefore, although both patients have a gene signature indicative of early death, one patient may 
survive a long time. This issue has recently been explored for invasive breast carcinoma where 
prognosis prediction was shown to be confounded by oestrogen receptor status, causing some samples to 
be systematically misclassified. Grouping patients by aspects of their clinical data before creating 
separate classifiers for those sample groups is a promising new research direction. It provides extra 
motivation for researchers not only to increase their sample sizes, but to obtain thorough clinical data, in 
order to make these analyses possible. 
In summary, compared to DE and DV, assessing genes via DD chooses different genes, selects features 
in a more stable manner, and provides competitive balanced error rates. DE classification only detects 
changes in means, and misses signatures of transcriptional deregulation. However, if the biological 
conditions being studied are rare, DE classification may be the only approach possible. The results 
presented here show that the DD approach selects a different set of features with greater biological 
relevance than DE, while maintaining good prognostic accuracy. DD classification is, therefore, a 
superior approach for assessing genes, which provides good classification accuracy and a 
complimentary set of biological features to DE or DV selection for biologists to pursue experimentally.
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4 
Performance of Proteomics 
Summarisation and 
Normalisation Methods
 
Proteomics promises to reveal the complexity underlying the mechanisms of disease and development 
by directly assaying the abundance of thousands of proteins, the functional end products of the central 
dogma of molecular biology. As with all omics technologies, preprocessing is crucial for obtaining 
accurate and precise measurements. To date, only a limited number of studies provide comparisons of 
preprocessing methods for proteomics data and none are comprehensive. The development of 
comparison studies which evaluate a specific platform is an on-going challenge and often requires 
specially designed experiments. A recently released experiment (P. Wang, Yang, Raftery, Zhong, & 
Wilson, 2013) based on a replicated Latin squares design consisting of 21 spike-in proteins ranging in 
abundance over 64 folds and a yeast proteome background has been utilised to evaluate a range of 
preprocessing options. This experiment now enables, for the first time in proteomics, the development of 
a comprehensive evaluation framework, similar to one created for Affymetrix gene expression arrays 
(Irizarry, Wu, & Jaffee, 2006). 
The evaluation of statistical methods for proteomics data is made possible by two main contributions. 
Firstly, a comprehensive set of performance metrics for a range of analysis scenarios have been 
developed, based on a replicated Latin squares experiment, enabling the thorough examination of 
sources of bias and variance. Secondly, a web-based application has been created that allows easy 
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summarisation of a large number of combinations of performance metrics and their distributions across 
various experimental aspects. This enables the scenarios in which a preprocessing method performs well 
to be identified. Notably, the web-based application is publicly accessible to anyone with an internet 
browser; users can upload their own preprocessed dataset to compare their own statistical methods in an 
unbiased way against those previously characterised. These developments allow the performance 
comparison of a range of important preprocessing decisions. Similar to the previous evaluation of types 
of changes by differential expression, differential variability, and differential distribution for 
classification problems (Chapter 3), combinations of numeric summarisation strategies are evaluated for 
the first time and recommendations about the most suitable approaches made. Additionally, the effect of 
between-sample correction methods is characterised. A large number of datasets for a variety of 
biological systems is becoming available to researchers through raw dataset repositories such as 
ProteomeXchange (Vizcaíno et al., 2014) and RefData (Gatto et al., 2016). Optimal preprocessing of a 
public dataset may reveal new findings which were missed in the original study. 
The remainder of this chapter is organised as follows. In Section 4.1, an introduction to proteomics is 
followed by a survey of existing evaluation datasets, metrics used, and benchmarking frameworks. 
Section 4.2 introduces the new performance metrics to evaluate bias and variance. Section 4.3 
demonstrates the key capabilities of the web-based application, such as user-preprocessed data upload 
and interactive performance metric summaries. Section 4.4 uses the web-based application to compare 
bias and variance of protein summaries in three different quantitation scenarios. Finally, in Section 4.5, 
the performance of the statistical preprocessing methods is discussed, and ideas for future work are 
proposed. 
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4.1 Background 
Firstly, an overview of protein identification and quantitation by mass spectrometry is made. Then, 
various designs for performance evaluation are introduced, their strengths and weaknesses are discussed, 
and their use in previous studies is highlighted. One specific replicated Latin squares design is focussed 
on, which forms the basis of the three case study evaluations presented in Section 4.4. 
4.1.1 Mass Spectrometry-based Proteomics  
Experiments to characterise the proteome begin by cutting the proteins into shorter amino acid 
sequences, called peptides (Rauniyar & Yates, 2014). The peptides are firstly separated based on their 
masses. Next, the peptides are subjected to two stages of mass spectrometry. In the first stage, the 
peptides are separated by their mass and charge. Before the second stage, the peptides are captured and 
broken in random positions. Ideally, each peptide is broken in a single location. The peptide sequences 
remaining after breakage are again measured in a mass spectrometer, and because there will ideally be a 
breakage between every amino acid, the difference between the masses of a sequence of length 𝑙 and 
length 𝑙 + 1 indicates what the 𝑙 + 1𝑡ℎ amino acid is. This allows the reconstruction of the entire 
sequence of the peptide. The determination of peptide sequence is difficult for many reasons. Some 
peptides are not broken in every possible position, which leads to ambiguities in the mass differences 
between consecutive peaks. This is because any two amino acids have the same total mass, no matter 
which order they are present in. Also, there are six types of breakages possible, and spectra tend to 
contain between two and three of them. 
Peptides can be quantified by a technique such as iTRAQ, which adds molecules of a known mass to the 
fragmented peptides. The labels are measured in a separate region of the spectrum to the peptides. This 
type of proteomics is called labelled and enables multiple biological samples to be measured together in 
a single instrument run. Two versions of the iTRAQ labels are available; 4-plex, which has four labels, 
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and 8-plex, which has eight. The other alternative, known as unlabelled proteomics, involves 
calculations (e.g. peak height, peak area) using the determined peaks in the first stage of mass 
spectrometry. Clearly, for unlabelled proteomics, only one biological sample may be analysed per 
instrument run. 
Determining the amino acid sequence for a spectrum, commonly known as Peptide-Spectrum Matching 
(PSM), is necessary to associate a spectrum with a known protein. The first software to perform this task 
was SEQUEST (Eng, McCormack, & Yates, 1994). The method is able to account for modified amino 
acids but has no statistical framework for controlling false discoveries. A few years later Mascot was 
released (Perkins, Pappin, Creasy, & Cottrell, 1999). It was the first software to have a statistical model 
that assigns a probability to each inference. More modern PSM algorithms, such as Paragon (Shilov et 
al., 2007) and MS Amanda (Dorfer et al., 2014), also have the ability to assign peptides to proteins when 
ambiguity exists. Peptide sequences may match multiple proteins in the database, but may be assigned to 
a particular protein after considering other peptides matching to unique portions of proteins. A 
comparison of a range of these algorithms and their performance on eight benchmarking datasets has 
recently been made (Tu et al., 2015), finding that no search algorithm had consistently superior 
performance. 
Once peptides are identified, uniquely matched to proteins and have quantities associated with them, 
they need to be summarised to the biological units of interest - proteins. There are many potential ways 
to summarise numerous peptide values into a single summary value for a protein. Popular approaches 
include the median peptide (Sturm et al., 2008), sum of the three peptides with the largest quantities 
(Ning, Fermin, & Nesvizhskii, 2012), and sum of all peptides divided by the number of theoretically 
observable peptides (Schwanhäusser et al., 2011). Summarisation methods can have significant impact 
on inferred protein quantities, but their evaluation has been limited in scope to date. 
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Finally, normalisation must be performed to remove sample-to-sample and batch-to-batch variability. 
Both of these unwanted kinds of variability would decrease the number of proteins statistically 
determined to be differentially abundant, if not accounted for. Many normalisation methods, such as the 
exponentially modified protein abundance index (Ishihama et al., 2005) and normalised spectral index 
(Griffin et al., 2010), are developed on label-free data and use spectral counts or peptide counts, which 
discard the rich quantitative information contained in iTRAQ experiments. Normalisation procedures 
such as median centering or z-score transformation of the precursor ion intensity (Webb-Robertson, 
Matzke, Jacobs, Pounds, & Waters, 2011), have also been infrequently used. However, this evaluation 
of normalisation approaches was based on unlabelled data and biological samples were used, which 
means the truth set of differentially abundant proteins is unknown. 
Unlike label-free experiments, labelled experiments inherently have batches of samples. Only one study 
has proposed a solution to remove such batch effects (Hill et al., 2008). A log-linear model with terms 
for various aspects of the experiment, such as iTRAQ channel and run number, as well as the 
experimental design, is fitted. Then, a normalised protein value is found by subtracting away the fitted 
coefficients for the technical effects. The performance of this method has not been evaluated 
independently. Other possible approaches include calculating a scaling factor for each sample, as 
ProteinPilot does, or using modern techniques such as Removing Unwanted Variation, commonly 
abbreviated to RUV (Jacob, Gagnon-Bartsch, & Speed, 2016). More details of these methods are 
provided in Section 4.4.2. These techniques, however, have not previously been evaluated in the 
proteomics field. In genomics, the MaQC-II study (Luo et al., 2010) corrected six datasets with different 
kinds of batch effects with five algorithms and the classification performance was found to be improved 
in the majority of scenarios for a subset of the correction algorithms. 
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The general process of converting the raw data obtained from a mass spectrometer into useful protein 
measurements is summarised by Figure 4.1. 
 
 
Figure 4.1 Flowchart of proteomics data preprocessing. Steps of preprocessing are 
represented by boxes and particular methods to evaluate are listed on the right side. Grey 
steps or option lists are not evaluated in this study. 
 
4.1.2 Evaluation of Quantitation 
All of the described preprocessing steps can have substantial effects on the protein measurement 
summary and motivate the need for evaluation of competing methods to determine which method, if 
any, is superior.  
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Evaluation in Genomics and Transcriptomics 
Much effort has been placed into designing experiments that facilitate the evaluation of competing 
algorithms in genomics and transcriptomics. The first study of its kind, AffyComp, came in response to 
the confusion and uncertainty surrounding the best-performing normalisation algorithm out of the many 
published (Cope, Irizarry, Jaffee, Wu, & Speed, 2004). It compared a variety of microarray 
normalisation methods on the basis of fourteen different performance metrics, using a spike-in Latin 
square design. The experimental design used had sixteen different transcripts spiked in at fourteen 
different concentrations. The concentration of a particular transcript differed on each of the fourteen 
microarrays. Metrics to evaluate bias were all based on the difference between observed and expected 
fold changes between consecutive spike-in amounts. Variance was evaluated by summarising the mean 
standard deviation of biological replicates and the IQR of log2-fold changes of genes unchanged in 
expression. This framework lead to the subsequent discovery that the background correction algorithm 
used is a critical step of data preprocessing (Irizarry et al., 2006). 
Another spike-in Latin square design enabled the bias and variance of different copy number prediction 
algorithms to be evaluated for the first time (Halper-Stromberg et al., 2011). The evaluation mostly 
consisted of an expected to observed fold change regression slope and replicate variability. Systematic 
bias such as the intercept of the regression line was not considered. This work is notable for comparing 
six different microarray models from three different manufacturers. Important conclusions to arise from 
this study were that there are strong artefacts in the raw data not corrected for by all manufacturer 
software except one, but corrected for by almost all academically-developed software. Between-
manufacturer evaluation also found that arrays made by NimbleGen had the best overall performance. 
This illustrates the importance of comparing data preprocessing software provided by the instrument’s 
manufacturer to software developed in academic research. 
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An immense variety of performance metrics have been used to recently evaluate RNA-sequencing 
experiments (SEQC/MAQC-III Consortium, 2014). Two samples, the Universal Human Reference and 
the Human Brain Reference, were mixed in ratios of 1:3 or 3:1 and distributed to seven research 
institutes around the world. This design creates a range of expected fold changes between 1/1000 and 
1000. Bias was evaluated by comparing the expected to measured fold changes. Variance was evaluated 
between samples at the same facility using the same or different instruments and also between facilities. 
The generated data was also processed with six different bioinformatics tools. This allowed a detailed 
characterisation of the sources of variability. The evaluation performed found that no approach could 
accurately quantitate absolute gene expression, but all approaches had similarly good performance for 
relative quantitation. A novel finding from this study was that gene expression microarrays showed 
higher reproducibility than RNA-sequencing between research institutes, which has implications for 
collaborative clinical research. Other recent evaluative efforts (Germain et al., 2016; Teng et al., 2016) 
provide similarly detailed recommendations about the best analytical choices for various scenarios. 
Evaluation in Proteomics 
Comprehensive evaluation of protein quantitation, rather than protein identification, has been rare for 
proteomics data. The best methods for most situations are still unknown. The earliest evaluation study 
consisted of six proteins spiked into a complex mixture at six different concentrations to form six 
samples, each measured by a separate unlabelled experiment (Mueller et al., 2007). Considered together, 
the six designed samples form a Latin square. Each sample was analysed three times. Performance 
evaluation was minimal; variance was indirectly assessed by clustering the samples using k-means 
clustering and also as the standard deviation of the three technical replicates for each protein. Bias was 
indirectly addressed by plotting the protein quantitation and expected quantitation of every sample. 
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Other limitations of the study are that no comparisons of any algorithms or parameters were done and 
the size of the spike-in proteins was not systematically varied in the experimental design. 
A small number of other datasets which make use of spike-ins at specific concentrations have been 
published (Mahoney et al., 2011; Tuli et al., 2012; Matzke et al., 2013; Pursiheimo et al., 2015; Shalit, 
Elinger, Savidor, Gabashvili, & Levin, 2015), but they have used simple dilutions of particular samples 
or compared two conditions which have a presence or absence of spike-in proteins. These studies do not 
allow the exploration of the interaction between protein amount and experimental quantitation, since it 
has not been controlled for. For instance, in Mahoney and others’ study, there are five quantity levels in 
the experimental design, but each protein only appears at two of the five levels. Another difference is 
that iTRAQ experiments have different quantitation characteristics to unlabelled experiments. Almost all 
prior evaluation studies are unlabelled experiments. iTRAQ experiments differ to these, as they have 
inherent experimental batches of either four or eight samples per batch and a downward bias of 
measured fold changes (Karp et al., 2010), particularly with single quadrupole time-of-flight instruments 
(Rauniyar & Yates, 2014). This means that findings from unlabelled experiments should not be 
extrapolated to labelled experiments. Additionally, the performance metrics evaluated have been limited. 
For example, Matzke and colleagues made conclusions focussed on method run time and software user 
interfaces, rather than the accuracy or precision of the normalisation methods compared. Tuli and others’ 
evaluation was only slightly more informative; it compared the number of statistically significant protein 
differences between two conditions processed by four publicly available preprocessing methods. 
Existing Evaluation Software 
Due to the rarity of comprehensively designed datasets in the proteomics field, there is limited software 
available to evaluate and compare preprocessing algorithm performance. Normalyzer (Chawade, 
Alexandersson, & Levander, 2014) is the first software that attempts to enable such comparisons. The 
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software allows users to load their proteomics dataset into R and applies twelve normalisation methods 
to it, such as LOESS normalisation, before producing simple dataset summaries, such as mean-variance 
plots. Normalyzer has a number of limitations. Firstly, it forces twelve normalisation methods to be 
applied to the dataset, disregarding whether the methods are applicable to the experimental design of the 
study. It provides no flexibility for the user to provide a dataset normalised using their own novel 
method. Secondly, Normalyzer is intended for generic biological experiments rather than designed 
evaluation studies, so the evaluations (e.g. coefficient of variation, quantile-quantile plots) are restricted 
to examining unwanted variance. Finally, unlike a web-based evaluation application, it is standalone 
software, and comparisons between methods of different researchers cannot be centrally disseminated. 
These limited comparisons of summarisation approaches and unevaluated batch correction methods 
motivate the systematic comparison of performance metrics with a well-designed dataset. 
Latin Square Evaluation Dataset 
A recently public dataset which allows for thorough examination of the sources of technical variability 
is utilised. The raw mass spectra and peptide-spectrum matches are available from ProteomeXchange as 
dataset PXD003608. The underlying experimental design and laboratory work were performed in 2012 
and the laboratory-based component of the project was done at the Bioanalytical Mass Spectrometry 
Facility at the University of New South Wales. 
The experiment consists of 21 known proteins, each purchased from Sigma-Aldrich (Table C-1) and the 
yeast proteome, to add background complexity to the protein mixture. The non-yeast proteins are 
referred to as spike-in proteins and yeast proteins are referred to as background proteins. The spike-in 
proteins selected for purchasing were based on characteristics such as protein purity, lack of overlapping 
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segments with background proteins, protein solubility, and the practical considerations of price and 
delivery time. More details about the choices made are available elsewhere (Wang et al., 2013). 
All proteins were labelled in each run with eight iTRAQ channels. For each experimental run, each 
spike-in protein was added at a different concentration in each iTRAQ channel, except in channel 121, 
referred to as the internal reference channel. The other seven channels are referred to as dynamic 
channels. A sample is defined as a particular iTRAQ channel of a particular experimental run. The 
proteins are grouped into seven groups, such that each group contains one small, one medium, and one 
large protein. The amount of each protein group used in each channel is shown for Run 1 (Table 4.1). 
The full design matrix is available as Table C-2. The spectral measurements were made with an AB 
SCIEX QStar Elite mass spectrometer. Spectra were acquired with Analyst QS 2.0 instrument software.  
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Table 4.1 Experimental Design for Run 1. The values in the table are volumes of diluted 
protein used, in units of microlitres. 
 Protein Group 
A B C D E F G Yeast 
iT
R
A
Q
 C
h
a
n
n
el
 
113 1 2 4 8 16 32 64 1 
114 2 4 8 16 32 64 1 1 
115 4 8 16 32 64 1 2 1 
116 8 16 32 64 1 2 4 1 
117 16 32 64 1 2 4 8 1 
118 32 64 1 2 4 8 16 1 
119 64 1 2 4 8 16 32 1 
121 8 8 8 8 8 8 8 1 
 
The Latin square dataset has been evaluated previously with the use of default normalisation settings in 
ProteinPilot (Wang et al., 2013), but only the regression slope of the entire dataset was evaluated, 
ignoring all aspects of variance and the effect of runs and channels on the slope metric. Therefore, the 
web-based application and proposed performance metrics are needed to comprehensively evaluate 
summarisation and normalisation methods of ProteinPilot and a variety of other methods. 
To summarise the raw data to normalised protein-level quantities, five out of six key stages of 
preprocessing were performed. Missing data treatment is not included because this dataset has a low 
percentage of missing peptides (Table C-3). Mass spectra were acquired from an ABI QStar Elite 
instrument. The spectra were searched using ProteinPilot’s Paragon method (Shilov et al., 2007) against 
a custom protein database, which contains all proteins for all of the source organisms in the March 2015 
release of SwissProt (Consortium, 2015) database. Version 5.0 of ProteinPilot was used. Parameter 
settings used by the algorithm were: 
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Cysteine alkylation: Iodoacetamide 
Protein digestion: Trypsin 
Special factors: Carbamidomethylation of cysteine, oxidation of methionine. 
Search effort: Thorough 
 
Approximately the same number of proteins were identified from the background set and the spike-in set 
(Table C-4). 
For peptide quantitation, the reporter ion areas were corrected for ion impurity using the default impurity 
table provided by ProteinPilot. Bias factor scaling and background correction were both turned off. 
Quantitated spectra were exported from ProteinPilot to text files using the Peptide Summary feature of 
the Export panel. Spectra were summarised to peptides by summing the areas for each channel for all 
spectra which had the same peptide sequence within each run and had confidence of more than 95%. 
These peptide summaries form the basis of subsequent summarisation and normalisation analyses in 
Sections 4.4.2 and 4.4.3. The data was also processed with the default bias and background correction 
steps, and evaluated in Section 4.4.1. 
4.2 Performance Metrics 
To comprehensively evaluate statistical methods in terms of bias and variance, eight distinct 
performance metrics are proposed for absolute and relative quantitation scenarios, providing a total of 
fifteen performance metrics. The metrics may further be categorised as regression metrics and 
summation metrics. 
Regression Metrics 
The regression metrics examine the relationship between expected log2-fold change vs. experimental 
log2-fold change based on a linear regression fit between these two fold changes. They are: 
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 Intercept: Ideally, the value is zero, which means that proteins which have no change are also 
measured as having no change. The further the intercept is from zero, the more systematically 
inaccurate the fold changes are. 
 Slope: An ideal value of one means that the measured fold change increase at the same rate as 
they do in the experimental design. Values between zero and one suggest that the fold changes 
are systematically underestimated. 
 Line Difference Sum: This variance-based metric is defined as the sum of the absolute 
differences between the fold change values predicted by the regression line and the expected 
values from the experimental design. It combines biases which affect either the slope or the 
intercept into a single value and provides an overall goodness of fit between the observed and 
expected fold changes. In a perfect situation, it is zero. 
 Residual Sum: This variance-based metric is the traditional sum of absolute residuals and is 
ideally zero. It could be close to ideal, even if the slope and intercept are far from their ideal 
values. 
Two kinds of regression lines may be constructed for this evaluation. All four of the above metrics may 
be calculated for both lines. In the absolute quantitation scenario, each protein summary in a sample is 
divided by the median summary of the proteins present at the median design amount of 8 µL in that 
sample. In this way, the measured amount of different proteins are directly compared to each other. The 
main experimental factors to affect these metrics are precursor ion coelution and different measurement 
efficiencies of different peptides. The second kind of linear regression is for relative quantitation. The 
protein summary of each protein is divided by the same protein’s summary in the internal reference 
channel. The key factors to affect these metrics are any systematic difference between the samples and 
also precursor ion coelution. These two regression lines provide a total of eight performance metrics. 
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Summation Metrics 
An additional set of metrics examines unwanted variance by considering the total amount of protein per 
channel, protein group, or experimental run based on summation within the particular grouping, 
followed by calculation of the coefficient of variation (C.V.). The ideal value for all summation metrics 
is zero. By design, all spike-in protein summaries for each dynamic channel have the same total amount 
of protein used. Also, every protein is present at the same total amount across all channels within a run. 
The metrics which make use of these important properties of the experimental design are:  
 C.V. Channel Sums: Protein summaries are summed within each iTRAQ channel and the C.V. is 
calculated. It provides an indication how similar channels are with each run and also in general. 
 C.V. Protein Group Sums: This metric is calculated by firstly summing the protein summaries of 
proteins within each protein group across all dynamic channels. Factors which affect this metric 
are proteins which have systematically high or low signal, undetected proteins, and binding of 
variable efficiency between peptides and particular iTRAQ labels. 
 C.V. Size Group Sums: Instead of grouping proteins by their allocated group in the experimental 
design, proteins are grouped into three size groups; small, medium, and large. Seven proteins 
belong to each group. This metric is particularly affected by the decreasing number of peptides 
available to calculate protein summaries, as protein size decreases (Figure C-1). 
 C.V. Median Run Proteins: The median spike-in protein summary is found for each run and the 
C.V. of those summaries is calculated. The factors which has the most effect on this metric are 
any extrinsic differences between runs, such as if the instrument has been recalibrated or 
differences in laboratory environmental conditions, such as room temperature. 
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The first three summation metrics are calculated within each run and also across all runs, resulting in six 
separate metrics. Therefore, there are seven summation metrics in total. 
None of the metrics use any protein summaries from the internal reference channel or the background 
proteins to ensure that metrics are independent of the protein summaries used for normalisation. All 
metrics, the scenarios they are relevant to, the preprocessing stages they are affected by, and the 
undesirable characteristic they evaluate are summarised in Table 4.2. 
Table 4.2 Summary of performance metrics and their characteristics. The applicability of a 
metric to the quantitation type, preprocessing stage, and error characteristic is shown. (R): only 
affects relative quantitation. The number next to the metric name shows its column name in the 
web-based application. 
 Quantitation Preprocessing Stage Characteristic 
Absolute Relative Summarisation Normalisation Bias Variance 
M
et
ri
c
 (
C
o
lu
m
n
 I
D
) 
Intercept (1, 5)      (R)   
Slope (2, 6)        
Line Difference 
Sum (3, 7) 
     (R)   
Residual Sum (4, 8)        
C.V. Channel Sums 
(9, 13) 
      
C.V. Protein Group 
Sums (10, 14) 
      
C.V. Size Group 
Sums (11, 15) 
      
C.V. Median Run 
Proteins (12) 
      
 
4.3 Web-based Application 
To enable the unbiased and reproducible evaluation of three novel case studies (Section 4.4) and also to 
allow researchers world-wide to develop their own data preprocessing methods and compare their 
method’s performance to existing approaches, a web-based application has been developed. Its URL is 
http://www.maths.usyd.edu.au/u/dario/Proteomics/pages/proteomeBenchmark.html 
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The web-based application has three sections; a help page, an evaluation matrix page, and a dataset 
upload page. To enable researchers to compare their novel methods with existing approaches, the New 
Processing Upload page (Figure 4.2A) enables users to upload their own preprocessing of the dataset for 
automated performance metric evaluation for the fifteen metrics defined in Section 4.2. It consists of a 
number of drop-down selection lists that are used to describe each of the main steps of standard 
proteomics data processing. If the user has a new method for a particular preprocessing stage, it can be 
typed in and will be added to the list of options. The application expects the input data to be a tab-
separated text file with one protein record per row, and columns for the protein identification, 
experimental run and quantity summary amount of each iTRAQ channel or alternatively the fold change 
to the internal reference channel. Absolute quantitation and summation metrics are not calculated if fold 
changes are provided. When the details of preprocessing and the quantitation table have been uploaded 
to the server, all possible performance metrics are calculated and the display is switched to the 
Evaluation Matrix page (Figure 4.2B). 
The Evaluation Matrix page is centred on an interactive performance metrics matrix. Each unique set of 
preprocessing parameters is referred to as a method set and forms one row of the matrix. The top row of 
the matrix is the row of ideal values for each metric, and has a golden background colour to provide a 
visual cue that the numbers are for the gold standard. The metrics are grouped by whether they are 
calculated on within-channel, within-run, or between-runs protein measurements. They are further 
grouped by whether they measure aspects of bias or variance. Each metric occupies one column of the 
matrix. To enable users to interactively make comparisons of their interest, the rows and columns of the 
matrix are selectable by left clicking the method set number or the metric number in the footer of the 
table. Once a subset of the matrix has been selected, the method sets may be evaluated either 
numerically or graphically. 
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Numerical comparison uses the selected metrics of the selected method sets to calculate the distance of 
each selected method set to the ideal metric value. The best method set has either the smallest sum of 
absolute distances to the ideal values (weighted voting), or the largest number of metrics closest to the 
ideal values (unweighted voting). The result text also provides the distance value or the metrics for 
which the method set was best for. Ties are handled by displaying all method sets which have the best 
set of metrics. 
Two kinds of graphical summaries are available. Firstly, the Plot PCA button makes a PCA plot of the 
method sets selected, based on the metrics selected. The method sets are projected into two dimensions. 
This enables the compact summarisation of method set performance similarity. Secondly, the Plot 
Comparison button causes either boxplots or bar charts to be generated of the selected subset of the 
matrix, depending on whether there are one or more summarised values, for each value of the x-axis 
variable. The plots can be organised into multiple rows and columns, by selecting one of the 
Methodology column names from the Rows By and Columns By drop-down lists. The Colour By list 
adds a third way to group metrics by in the plot. Therefore, the application allows up to three 
methodology factors to be visualised simultaneously. 
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Figure 4.2 Overview of the web-based application for evaluation. A. The New Processing 
Upload page allows users to describe various aspects of their data preprocessing and to 
upload the protein quantities or fold changes as a text file to the server. The web-based 
application calculates all of the performance metrics and then automatically switches to the 
Evaluation Matrix page. B. The Evaluation Matrix page displays the matrix of performance 
metrics and various tools to interact with it. The numbers in the table are summaries, either the 
mean or standard deviation of the metric, of either all experimental runs or all iTRAQ channels, 
where applicable. Filtering, sorting, row and column selection are used to subset the matrix to 
the comparison of interest. Full metric names can be seen by hovering the mouse over the 
column number. Numerical and graphical evaluation tools are located below the metric matrix. 
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4.4 Case Studies 
The utility of the proposed evaluation metrics and web-based application are illustrated by their 
application to three analysis scenarios, each examining the performance of preprocessing methods for 
either relative or absolute quantitation. The first scenario involves the use of a commercial software, 
ProteinPilot, to calculate protein-level relative quantitation. Secondly, the performance characteristics of 
custom relative quantitation are evaluated, using peptide summarisation methods and between-sample 
normalisation methods popular in academic research. Finally, a novel scenario of performing absolute 
quantitation without use of internal standards is examined. 
Between-sample and between-run normalisation are of interest because clustering of samples by iTRAQ 
channel and, to a lesser extent, run can be seen in PCA plots of the background protein summaries 
(Figure C-2). Samples measured by the internal reference channel are expected to be located away from 
the other seven channels, where the proportion of yeast proteins (1 µL:57µL) is larger than for the other 
channels (1µL:128µL), so the PCA plot is consistent with theoretical expectations. 
4.4.1 Case 1: Preprocessing with ProteinPilot 
Two key steps of ProteinPilot processing are bias and background correction. The bias correction step 
aims to make samples more comparable to each other by calculating the ratio to the internal reference 
channel for all proteins within a sample and representing a sample by the median ratio. By a process not 
described in the software documentation, scaling factors are calculated to make the median ratio of all 
samples equivalent. From the design matrix (Table C-2), because each dynamic channel contains the 
same protein volumes in a different permutation, the theoretical median fold change of each dynamic 
sample to the reference sample is the same, so this normalisation approach is applicable to the dataset. 
The following step, background correction, is intended to make fold changes closer to their true values. 
It affects each protein within a sample differently. In the software documentation, it is stated to be 
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problematic with datasets where the proteins with the highest expression amount are mostly 
differentially expressed. This is true for the experimental design used by this case study, where the yeast 
proteins are present at much lower abundances than any of the spike-in proteins. Only the regression line 
for relative quantitation is evaluated, since the software does not output the numerator and denominator 
it uses, only the calculated fold change. 
Most distributions of the slope of the regression line have a median close to the ideal value of 1 (Figure 
4.3). The slopes for channels 113 and 118 are particularly good, having little variance and being the very 
close to 1. Channel-specific biases are evident, with the Intercept metric of channels 114 and 115 having 
intercepts around -2. The biases also adversely affect the Line Difference Sum metric of those two 
channels. There is noticeably less variability between runs than between channels. The low bias comes 
at a cost of increased variance. The medians of the Residual Sum metric are increased in comparison to 
the unnormalised dataset, presented in the following section. 
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Figure 4.3 Performance metrics of regression for relative quantitation using the default 
processing parameters of ProteinPilot 5. Horizontal red line represents the ideal metric 
value. Metrics are grouped either by iTRAQ channel (first row) or run (second row). 
 
4.4.2 Case 2: Custom Relative Quantitation 
Motivated by their usage in published proteomics research (Section 4.1.1), the summarisation 
approaches of peptides to a particular protein evaluated in this case study are:  
Top 1 Peptide: The peptide with the maximum signal is used. 
Top 3 Peptides: The peptides with the three highest signals are summed. 
Median Peptide: The peptide with the median signal is used. 
The normalisation methods between samples are: 
Simple Scaling: This simple method is based on correcting the sample-to-sample variability within each 
run by calculating scaling factors using only the yeast protein summaries. Every channel has the yeast 
proteome added at the same quantity (e.g. Table 4.1). Firstly, a representative control quantity value for 
each sample is calculated. Four options are considered: 
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Top 1 Yeast Protein: The yeast protein with the highest summary in each sample. 
Top 3 Yeast Proteins: The proteins with the three largest summaries in each sample are 
summed. 
Median Yeast Protein: The median of the yeast protein summaries in each sample. 
All Yeast Proteins: The sum of summaries of all yeast proteins in each sample. 
Next, a scaling factor is calculated by dividing the representative value of the internal reference channel 
to the representative value of each dynamic channel. Every protein in a dynamic channel is multiplied 
by the calculated factor for that channel. This procedure is done independently for each run. 
Two-stage Scaling: The first step is identical to Simple Scaling. In the second stage, another set of 
scaling factors to multiply entire runs by is calculated. The four ways of calculating a representative 
value are used, this time considering all yeast proteins within a run. A scaling factor is calculated by 
arbitrarily picking one run to be the reference run and then dividing the representative value of its 
representative value by each other run’s representative value. Lastly, all proteins within a run are 
multiplied by the calculated factor for that run. 
Linear Model: A more complicated approach involves fitting a linear model to the subset of the yeast 
proteins which were measured in every run of the experiment (Mahoney et al., 2011). Here, a modified 
version of the published model is used that does not include a peptide effect: 
𝑦𝑖𝑗𝑘 =  𝜇 + 𝑟𝑢𝑛𝑖 + 𝑐ℎ𝑎𝑛𝑛𝑒𝑙𝑗 + 𝑟𝑢𝑛𝐶ℎ𝑎𝑛𝑛𝑒𝑙𝑖𝑗 + 𝑝𝑟𝑜𝑡𝑒𝑖𝑛𝑘 + 𝜖, 
y is the log2-transformed protein summary value of a protein in run i, measured in channel j of protein k. 
The term µ is the intercept term, runi is the effect of the i
th
 run (𝑖 ∈ {1. .7}), channelj is the effect of the 
j
th
 channel (𝑗 ∈ {113, 114, 115, 116, 117, 118, 119, 121}), the interaction term runChannelij is the 
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sample-specific effect, proteink is a factor for each of the yeast proteins detected in all runs, and 𝜖 is for 
the other sources of technical variability. The corrected protein summary value, denoted z, is simply 
corrected by subtracting the unwanted fitted effects from the observed summary value of spike-in 
protein k: 
𝑧𝑖𝑗𝑘 = 𝑦𝑖𝑗𝑘 − 𝑟𝑢𝑛𝑖 − 𝑐ℎ𝑎𝑛𝑛𝑒𝑙𝑗 − 𝑟𝑢𝑛𝐶ℎ𝑎𝑛𝑛𝑒𝑙𝑖𝑗 
RUV: The most complex method for making corrections is a recent extension to the RUV technique 
(Jacob et al., 2016), which can correct a dataset when the unwanted experimental factors are unknown in 
advance and neither is the factor of interest (e.g. disease status). Like the two-stage scaling and linear 
model approaches, this method makes use of control features present in each sample. The model being 
fitted is: 
𝑌 =  𝑋𝛽 +  𝑊𝛼 +  𝜀, 
where 𝑌 is a 𝑚 × 𝑛 matrix of 𝑚 samples and 𝑛 feature measurements, 𝑋 is a 𝑚 × 𝑝 matrix where the 𝑝 
columns contain the factors of interest (e.g. disease subtype), 𝑊 is a 𝑚 × 𝑘 matrix that contains the 𝑘 
unwanted factors causing noise (e.g. experimental batch), and 𝜖 is some random noise, assumed to be 
normally distributed. This version of RUV differs to previous versions in that the algorithm to estimate 
the 𝑊𝛼 does not require classes to be assigned to the samples. 
 Any systematic bias will be present in all proteins, including those known to be unrelated to actual 
differences between samples. For this reason, the yeast proteins are key to RUV normalisation. The user 
has to provide an estimate of the number of independent factors thought to be biasing the measurements, 
termed the rank parameter, and a second parameter to fine-tune how much of the estimated unwanted 
variation is removed from the dataset, termed the regularisation parameter. 
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All of these procedures mainly aim to improve relative quantitation bias, because systematic differences 
between samples are accounted for. Variance of relative quantitation and some of the summation metrics 
which use summaries from multiple samples is also ideally reduced, because the variability between 
samples is reduced. Apart from Simple Scaling, all of these procedures also aim to reduce variability 
between runs. 
Each of the normalisation methods with parameter choices was evaluated independently, to reduce the 
complexity of comparison between them (Section C-3). For the two scaling methods, Median Yeast 
summarisation of a sample performed best in the most number of categories (Table C-5A) and will be 
used as the summary for each sample to calculate a scaling factor with. For RUV, the performance 
metrics were rather sensitive to the choice of parameters (Table C-5B). The RUV software uses a default 
of 𝑘 equal to the number of samples and 𝜈 equal to 0.001 and these values are used in subsequent 
comparisons. 
The Simple Scaling, Linear Model and RUV methods all produce similar biases to fold changes (Figure 
4.4). For example, channels 114 and 115 have a median intercept of about -2, and the variability of this 
across runs is small. Also, channel 117 has an intercept of around 1, with little variation across runs. In 
contrast, when the intercepts are grouped by run, the distributions are centred close to 0, although the 
spread is much larger. The unnormalised intercepts are all around -2, due to the different total volume in 
the internal reference channel to the dynamic channels and the compositional nature of the data. The 
spread of the intercepts between channels for the unnormalised summary is much less than for any of the 
normalised summaries, demonstrating that normalising using the yeast protein summaries introduces 
additional unwanted variation when removing bias. 
The slope coefficient is particularly far from ideal for channels 114 and 115, with a median value of 
about 0.25. When considering the slopes being grouped by runs, all runs are rather consistent with 
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medians close to 0.5. The Residual Sum’s median is typically around 15, with little variation between 
groupings. The peptide to protein summary type has no substantial effect on any of the metrics. 
The intercept is the only metric affected by the normalisations, so the distribution of intercept metrics of 
all four approaches is shown. The Slope and Residual Sum are unaffected by between-sample 
normalisation methods and only the metrics for the unnormalised dataset are shown. Applying a 
multiplicative scaling factor to a sample causes the points used to fit the regression line to be translated 
up or down because the fold changes are represented on the logarithmic scale. Without loss of 
generality, a proof is provided in Section C.4 for the case of two vectors consisting of two measurements 
each. 
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Figure 4.4 Performance metrics for relative quantitation. Horizontal red line represents the 
ideal metric value. 
 
4.4.3 Case 3: Absolute Quantitation 
The linear regression of expected to measured fold changes for this novel scenario has an intercept and 
slope similar to what is theoretically expected (Figure 4.5A). No normalisation methods are applied, 
because they normalise between samples whereas these metrics use only within-sample protein 
summaries. The intercepts of the linear fit tend to be slightly positively biased, which suggests that the 
median protein summary used as the denominator of the fold change is typically lower than expected. 
As for custom relative quantitation, the slopes are all well below 1, regardless of the run, channel or 
summary method used. The Median summarisation has the worst median slope estimates for all seven 
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runs and five out of seven channels. The variability of the metrics is not greatly different between the 
summarisation varieties, as shown by similar IQRs within each figure panel. 
Regarding the summation metrics which sum across different samples, no normalisation method 
performs consistently better than the others (Figure 4.5B). RUV results in the greatest improvement of 
the within channel C.V.s, but only for runs four, five, and six. For the other four runs, all methods result 
in similar C.V.s. Simple Scaling is the best method, but by only a small margin, for the C.V. Median 
Proteins metric. The C.V. of all of the measurements in a channel across all runs is approximately the 
same as the C.V. within each run, showing that there is little additional unwanted variability present 
between runs. Notably, the C.V. increases with run number for Top 1 and Top 3 summarisations, 
suggesting a relationship between the length of time the protein mixture was stored before analysis with 
the mass spectrometer and the magnitude of measurement variability. 
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Figure 4.5 Performance metrics for absolute quantitation. Horizontal red line represents 
the ideal metric value. A. The distribution of metric values of a linear regression of protein 
summaries within a sample divided by the median protein group’s median summary of the 
sample, grouped either by iTRAQ channel or experimental run. B. Summaries for three 
variance metrics calculated using data from either one run or all runs. 
 
4.5 Discussion and Conclusion 
 
93 
4.5 Discussion and Conclusion 
This study has made two main contributions to proteomics. Firstly, a range of performance metrics 
which allow the systematic evaluation of bias and variance were defined. Secondly, a web-based 
application for performance evaluation has been made available for the first time to the proteomics 
research community that allows exploration of a large variety of performance metrics applicable to 
different research questions. A number of interesting findings resulted from comparisons made with this 
web-based application. 
The web-based application is notable because it allows the upload and comparison of new preprocessing 
method summaries, unlike other recent proteomics performance evaluation efforts (Mahoney et al., 
2011; Tuli et al., 2012; Goeminne, Gevaert, & Clement, 2016). It also calculates a broader range of 
metrics than existing studies, allowing more detailed comparisons of runs, channels, and proteins to be 
made. Another advantage is that the results are publicly accessible, which provides unhindered access to 
scientists to search for the best preprocessing method for a particular analysis scenario. The raw dataset 
is available from ProteomeXchange and the file input requirements are clearly explained in the 
application’s documentation, enabling summaries from novel methods to easily be added to the existing 
metrics table. No software installation or computer programming knowledge is required, providing 
accessibility to the broader research community. 
The application of the web-based application in three case studies resulted in a number of interesting 
observations. Firstly, there are no major differences between protein summary methods or between-
sample normalisation methods. A previous analysis of protein summaries lacked a statistical 
experimental design and made no conclusions (Matzke et al., 2013), leaving the research community 
uncertain about which approach is the best. The results of Section 4.4.2 demonstrate that there is little 
difference for most performance metrics between all three summarisation approaches. Metrics for 
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Median summarisation tend to be closer to zero than for the other two approaches, suggesting that it is 
discarding some useful information. Also, complex methods for between-sample normalisation like 
RUV perform almost identically to the simple scaling approaches, as seen in Figure 4.4. These results 
suggest that RUV captures the same sources of unwanted variation that a computationally fast to 
calculate scaling factor does. RUV has only been evaluated on a dataset chosen by the authors who 
developed the method and QPEP suggests that the performance of the algorithm may not be as good as 
claimed when independently evaluated. There appears to be no good reason to use RUV for relative 
quantitation when a much simpler method works equally as well. 
A second surprising observation is that ProteinPilot’s background correction works well in a dataset 
where the majority of detected proteins are differentially expressed. The method is not described in 
mathematical detail by ProteinPilot’s documentation and is suggested by the documentation to perform 
poorly when the majority of proteins change in abundance. Moreover, it has never before been 
independently evaluated. The slopes of the regression between expected and observed log2-fold changes 
improved from about one half for all custom normalisation methods tried to nearly one when 
background correction was used. This improvement in bias did come with an increase in variance, 
however, which would adversely affect differential protein expression studies in practice, where the 
increased variance could result in too many false negative findings. 
Thirdly, a longstanding rule in omics research that one should not compare measurements between 
different genes or proteins appears to be unnecessary. The current approach to absolute quantitation is to 
add stable-isotope labelled standards to every sample and create a linear model for the known 
concentration of peptide and experimentally-measured amount (Scott, Turko, & Phinney, 2015). This is 
time-consuming and expensive, because internal standards must be created for every peptide of interest 
(Villanueva, Carrascal, & Abian, 2014). It is infeasible to take this approach for shotgun proteomics 
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experiments because of the number of distinct standards which would be necessary, so almost all 
published work takes the ratio of each protein summary to its summary in the reference channel. 
Comparing Figure 4.4 to Figure 4.5 suggests that this daunting task may not be necessary. The slopes of 
the regression between expected and observed log2-fold changes are essentially the same as for relative 
quantitation. Moreover, the intercepts are noticeably better for absolute quantitation than for any of the 
normalisation methods applied in the relative quantitation setting. Remarkably, the distribution of the 
intercepts were strongly associated with the iTRAQ channel, although the yeast proteins were scaled to 
have a fold change of 1. This suggests that different iTRAQ labels may have different measurement 
characteristics. The performance of absolute quantitation without internal standards suggests that 
reserving one channel for an internal standard to perform relative quantitation is unnecessary and more 
biological samples could be analysed in less runs of the instrument by not having reference channels in 
an experimental design. 
Finally, there is much less observed variability between instrument runs than there is between iTRAQ 
channels. This has important implications for experimental design. Most published articles do not use 
the statistical principles of randomisation and blocking when designing their iTRAQ-labelled 
experiment (Leong et al., 2012; Xu et al., 2015; Kim et al., 2016). Unless the findings of these projects 
are validated by an independent technique, such as Western blotting or reverse phase protein arrays, it is 
unclear whether the differences in protein amount are the result of the biological conditions studied or 
simply an artefact of the iTRAQ channels inadvertently used for each condition. 
In summary, a range of performance metrics and a web-based application have been described, which 
allow for the comprehensive evaluation of bias and variance in a carefully designed iTRAQ spike-in 
experiment. A number of interesting observations were found in three case studies, which have potential 
consequences for existing and future proteomics experiments. In the future, it would be interesting to 
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compare an LC-MS/MS experiment that has been background corrected by ProteinPilot to an LC-
MS/MS/MS, or MS3, experiment of the same samples, which is a laboratory approach to addressing the 
underestimation of fold changes in iTRAQ experiments (Ting, Rad, Gygi, & Haas, 2011). Which 
approach results in measurements with smaller variance is also unknown. Another outstanding issue is 
that ProteinPilot does not have any user options regarding peak quantitation. Methods such as peak area, 
peak summit height, and different types of peak area integration could be implemented and their 
evaluation carried out. Additionally, the poorer performance of iTRAQ channels 114 and 115 relative to 
the other six channels warrants further investigation. It may have only occurred for the reagent batch 
used by this study or may be systematically affecting all experiments which utilise iTRAQ labels, the 
majority which do not randomise experimental conditions to channels.
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Conclusion 
 
This thesis has demonstrated that each type of omics technology generates data with a plethora of 
summarisation and normalisation options. This presents the opportunity for the development of novel 
methods to improve classification or numerical summarisation performance. Each data type has unique 
characteristics which had to be understood in order to develop a new method or to systematically 
compare existing methods and select the superior method in each scenario. The three main contributions 
have been the development of a two-stage algorithm to perform region-finding and region classification 
for CAGE-seq data, the characterisation of feature selection and prediction by differential distribution 
for the first time with a novel software framework (ClassifyR), and the development of a large variety of 
performance metrics and a web-based application that allows anyone to verify the performance of a 
method and to compare their own methods against methods which are currently widely used by 
researchers. 
The CAGE-seq region finding algorithm is notable for its simplicity and speed, while using an improved 
background model compared to F-seq, and not returning a lengthy list of regions and forcing the user to 
manually choose the most representative regions, like Paraclu (Section 2.2.1.1). The previous work on 
classification of regions was also found to be limited, with only two methods attempting to provide a 
solution to the problem of classifying regions as TSS or other artefacts. The proposed method 
outperformed both ENCODE-HMM and Segway (which does not use CAGE-seq data), when evaluated 
by precision and recall. One surprising finding was that integrating CAGE-seq data with matched RNA-
seq data provided little benefit to classification performance. 
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Prognosis classification is another area of statistical bioinformatics where the accuracy of existing 
methods leaves room for improvement. Classification has traditionally been focussed on changes in 
location between classes (Section 3.1), but the present study found that changes in scale, or the 
combination of changes in location and scale, modelled by a novel differential distribution framework, 
had equivalent balanced error rates to existing methods, but provided significant advantages in terms of 
feature selection (Section 3.5). These findings suggest that classifiers built on differential distribution 
may provide more informative and more stable features in terms of biological relevance. The median 
cross-validated error rates of around 25% are better than those based only on clinical data, which is the 
current standard in clinical care, but are still higher than what clinicians desire. Future work could 
involve vertical data integration, when more complementary datasets (e.g. metabolomics, proteomics) of 
the same patients become available as data acquisition becomes simpler and cheaper with technological 
advancements. Biological systems are complex, and more of the variability between samples and their 
prognosis could potentially be explained with more orthogonal measurements of the same patient 
sample. 
Much like the comprehensive evaluations for CAGE-seq and gene expression in earlier chapters, novel 
comparisons have provided evidence for performance improvements in proteomics data analysis 
(Chapter 4). No other evaluation has developed as many different performance metrics to characterise 
bias and variance or used an experimental design where the factors were exhaustively varied. Moreover, 
the novel web-based application is a substantial improvement over the numerous published research 
studies that do not provide reproducible code to replicate their findings or the possibility to compare 
future findings with theirs in a streamlined way. This framework enabled the discovery that commercial 
software performs quite well in comparison to academic approaches (Section 4.4.1) and that complex 
statistical approaches have no benefit over the simplest of scaling approaches (Section 4.4.2). It was also 
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surprising that performing absolute quantitation without internal standards performed just as well as 
relative quantitation (Section 4.4.3). This casts doubt on a widespread rule in omics research about not 
comparing measurements of different features directly and creates opportunities for new types of within-
sample analysis. 
The statistical approaches proposed in the preceding chapters have provided new ways to summarise, 
normalise and evaluate omics datasets that measure various stages of the central dogma of molecular 
biology, from transcription (Chapter 2) to proteins (Chapter 4). Their implementations have been made 
available through online software repositories or web applications, to enable others to use them on their 
own datasets and be able to improve upon them. Novel findings which improve classification or numeric 
summarisation have been presented across all three topics and challenges which remain unresolved have 
been outlined. 
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A  
Supplementary Material For 
Chapter 2 
 
A.1 Region Finding Visual Evaluation 
It has been shown in Section 2 that almost all of the regions found by the proposed method are found by 
Paraclu and F-seq. This is because the proposed method finds a subset of regions using its null model. A 
representative genomic region is illustrated in Figure A-3, which shows the histogram of read counts, 
along with a track of regions for each method. Paraclu returns a large number of overlapping results, 
leaving it to the scientist to decide which region they think is the most representative of the data. This is 
infeasible to manually do for all of the regions found by Paraclu. Paraclu also includes large regions 
with no signal in the raw data, such as the left half of the figure. F-Seq identifies the key region in the 
centre of the figure, but also identifies many regions that are supported by only one read. These regions 
are not found by the proposed algorithm, perhaps because of the effective determination of the null 
distribution. These issues are observed for all six cell lines. 
A.2 Feature Selection 
 
101 
   
Figure A-1 Raw counts and detected regions for sample GM12878. The first two rows show 
the counts at each position of the first positions of CAGE reads. The Genes row shows a 
model of known genes in this region. The left-most edge of the blue rectangle is a known TSS. 
The thin blue lines are known introns. The bottom three rows show the regions determined by 
each of the three methods compared. The angle brackets show the strand on which the 
regions are. “>” represents the plus strand and “<” represents the minus strand. 
 
A.2 Feature Selection 
Features were chosen based on having an absolute correlation of above 0.5 to the first principal 
component of the PCA. The 2D PCA plot using the six scalar features and another plot using the 512 4-
mer sequence counts are shown below. The scalar features used here are kurtosis, read density, TFBS, 
DNAse I hypersensitivity, H3K4me3 hypersensitivity, and mammalian conservation. 
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Figure A-2 Principal 
components analysis of 
the scalar features 
surrounding the CAGE 
read regions. The top 
panel shows the TSS 
category of regions and the 
bottom panel shows those 
regions which are labelled 
as Not TSS in the truth set. 
Dots represent the 100 
observations in the lowest 
density regions. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-3 Principal 
components analysis of 
the 4-mers surrounding 
the CAGE read regions. 
The analysis was 
performed on the 
correlation matrix of the 512 
4-mers. The top panel 
shows the TSS category of 
regions and the bottom 
panel shows those regions 
which are labelled as Not 
TSS in the truth set. Dots 
represent the 100 
observations in the lowest 
density regions. 
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A.3 Parameter Tuning 
Linear SVMs have a single tuning parameter; the cost parameter. It controls how much incorrectly 
classified samples are penalised during the fitting of the separating hyperplane parameters. A grid of 
cost values was chosen and the precision and recall metrics are shown to be stable for a large range of 
the cost parameter. 
 
Figure A-4. Precision and recall for three feature scenarios. Precision and recall are 
calculated at each cost parameter value based on a LOOCV scheme. Blue lines are precision. 
Red lines are recall. Horizontal bars or dots represent the minimum and maximum value of all 
cell lines. Points on the line are averages across all six cell lines for the two leftmost panels 
and two cell lines for the rightmost panel.  
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A.4 Classification Performance 
The precision and recall metrics for the six cell lines are shown for three dataset scenarios. Minor 
improvements in recall are made by incorporating the matched external feature. 
Table A-1 Precision and recall for three dataset scenarios. Internal scenario uses selected 
4-mers. Internal and Pooled External scenario uses selected 4-mers and Maximum H3K4me3, 
Maximum TFBS, Maximum Sensitivity, and Average Conservation features. Internal and 
Matched External scenario uses selected 4-mers and Poisson test of flanking RNA-seq counts, 
matched to each cell line. Grey cells indicate evaluations for which data is not available. 
 
Internal 
  
Internal and 
Pooled External 
  
Internal and 
Matched External 
  
Cell Line Precision Recall Precision Recall Precision Recall 
GM12878 0.77 0.81 0.76 0.81 0.75 0.84 
H1-ESC 0.61 0.81 0.63 0.80 0.74 0.84 
HeLa-S3 0.76 0.87 0.79 0.84   
HepG2 0.69 0.79 0.76 0.75   
HUVEC 0.81 0.85 0.81 0.85   
K562 0.71 0.88 0.82 0.81   
 
A.5 Prostate Cancer Case Study 
Plots of the counts in the regions identified for the gene with the best differential expression and TSS 
switching statistics are shown. 
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Figure A-5. CAGE count summaries for the genes with the best differential expression 
and TSS switching statistics. The top two rows of data show normalised count values per 
genomic position in each of the two experimental conditions. The third row of data shows the 
structure of known genes. The bottom row shows the regions which have been classified as 
TSS regions.
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B  
Supplementary Material For 
Chapter 3 
 
B.1 ClassifyR Runtime 
Two-class classification using ClassifyR was done on the melanoma dataset introduced in Section 3.5. 
DLDA was used for DE classification and FLDA was used for DV classification. DE feature selection 
used the limma moderated t-statistic. DV feature selection used the Levene statistic, which involves 
repeatedly calculating medians for every feature, which explains the much slower timings of DV 
classification than for DE. The runtimes approximately halves as the processors are doubled from one to 
eight processors, but the improvement is much diminished for 16 processors. 
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Table B-1 Classification runtime using ClassifyR. DE and DV classification were evaluated 
in two cross-validation modes, using between 1 and 16 processing cores. 
Feature Type Cross-validation Cores 
Time 
(minutes:seconds) 
Expression 
100 resamples, 5 folds 
1 14:54 
2 7:51 
4 4:21 
8 2:30 
16 2:03 
Leave-2-out 
1 32:42 
2 17:32 
4 9:14 
8 5:34 
16 4:18 
Variability 
100 resamples, 5 folds 
1 669:55 
2 357:02 
4 207:46 
8 125:24 
16 91:31 
Leave-2-out 
1 1446:41 
2 782:13 
4 408:50 
8 262:55 
16 210:00 
 
B.2 ClassifyR Parameters 
Each of the four stages of classification require some specific parameters. All parameters for a particular 
stage are stored in a class. These parameters are summarised in the table below. 
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Table B-2 Parameter classes and their required variables. Classes that store parameters 
for each stage of classification and the meanings of each parameter. Any other variables can 
be stored and used, as long as the function which performs the particular stage knows how to 
use them. In addition, all classes use a parameter intermediate, which is a character vector 
of variable names generated internally by runTest that will be used in the classification stage 
the class represents. 
 
Each of the functions used in the four stages also has rules about arguments it must conform to. 
Transform Function: The first argument must be a matrix of data. It returns a transformed matrix of the 
same dimension as the input matrix. 
Selection Function: The first argument must be a matrix of data. It returns a SelectResult object. 
Training Function: The first argument must be a matrix. This is because most other R classifiers on 
CRAN take matrices. The second argument must be a factor of classes of the training samples. The 
Class 
Mandatory 
Parameter 
Description 
TransformParams transform 
Any function that transforms a matrix of numbers and 
returns the transformed matrix of numbers. 
SelectParams 
featureSelection 
Any function that takes a matrix of numbers and returns 
a vector of indices, representing the features that were 
chosen. 
subsetExpressionData 
If TRUE, subsets the expression values. If FALSE, only 
returns the vector of indices of chosen features. 
TrainParams classifier Any function that builds a classifier. 
transposeExpression 
Some existing classifiers in R require the features to be 
columns. If set to TRUE, the data matrix is transposed 
before being dispatched to classifier. 
doesTests 
If set to TRUE, notifies the framework that 
classifier should also be used as the prediction 
function. Some functions do both training and testing. 
PredictParams 
predictor 
A function that uses the model built in the training stage 
to make predictions on test data. 
getClasses 
A function that takes as input the output of 
predictor, or classifier if doesTests is 
TRUE, and extracts a vector of predicted classes. 
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function returns a trained model. If doesTests is TRUE because the function also makes predictions 
using the test set samples, the third argument must be a matrix of test set values. 
Prediction Function: The first argument must be a trained model that was generated by the training 
step. The second argument must be a matrix of test data. It returns an object containing predictions. 
Apart from these mandatory arguments, the functions may have any other arguments they wish to. 
An example of a function which does not conform to these rules is 𝑘 nearest neighbours. It has the 
classes of the training set as the third argument, whereas ClassifyR expects it to be the second argument 
and the matrix of test values to be the third. However, a simple wrapper function enables it to work with 
the framework, simply by referring to the wrapper function, instead of the original function. 
 
B.3 Properties of Biological Datasets 
In the biological study, two classes were created by using a cut-off on the number of years since the 
patient was diagnosed and whether they are alive or dead (Section 3.5). This excludes a number of 
samples for the evaluation. The survival times of all samples in the datasets are alternatively presented 
as two groups, based on whether they are alive or dead. The lung cancer dataset has very few patients 
who were followed for more than three years. 
knnWrapper <- function(exprTrain, classesTrain, exprTest, verbose, ...) 
{ 
  knn(train = exprTrain, test = exprTest, cl = classesTrain, ...) 
} 
 
training <- TrainParams(knnWrapper, 
                         transposeExpression = TRUE, doesTests = TRUE) 
result <- runTests(aDataset, "Dataset Name ", "Classifier Name", 
                   params = list(SelectionParams(), training, 
                                 PredictParams() 
                                 ) 
                  ) 
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Figure B-1 Distribution of survival times for the three cancer datasets used for 
classification evaluation. Densities are estimated with the default Gaussian kernel in R. 
 
B.4 Most Stable Feature 
For the three cancer datasets, the gene which was selected the greatest number of times in cross-
validation was found. The plot of the class distributions is shown below. For the DV and DD rows, the 
variety of selection found to perform the best in the simulation study (Section 3.4) is used. That is, 
Bartlett’s test is used for DV and the DMD statistic is used for DD. As expected, Bartlett’s test chooses 
genes which have a small number of outliers in one class. 
B.4 Most Stable Feature 
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Figure B-2 Most frequently chosen genes’ expression profiles in cross-validation for 
three datasets and three feature types. The RefSeq symbol of the gene the densities are 
plotted for is shown above each density plot. DV selection is made by ranking of the Bartlett’s 
test statistic and DD selection is made by the proposed DMD statistic.
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C  
Supplementary Material For 
Chapter 4 
 
C.1 Full Specification of Latin Squares Experimental Design   
The experiment consists of 21 proteins of known identity and the yeast proteome which has an unknown 
composition. The assigned group, name, database ID, length, and source organism are specified below.  
Table C-1 The identities of purchased proteins and their associated information. Group 
denotes the allocated group label of each protein, so that a variety of sizes are in each group. 
Group Protein Name SwissProt ID Amino 
Acids 
Organism 
A Thioredoxin P10599 105 Human 
A Glutathione S-Transferase P08515 222 Schistosoma japonicum 
A Antithrombin III P41361 465 Cow 
B Polyubiquitin B P0CG47 76 Human 
B DNase I P00639 282 Cow 
B Catalase P00432 527 Cow 
C Alpha-lactalbumin P00711 142 Cow 
C Quinone Oxidoreductase 2 P16083 231 Human 
C Gelsolin P06396 782 Human 
D Beta-2-microglobulin P61769 119 Human 
D Ubiquitin-conjugating enzyme E2 E1 P51965 193 Human 
D Amylase P06278 512 Bacillus licheniformis 
E Cytochrome c P00004 105 Horse 
E C Reactive Protein P02741 224 Human 
E Serum Albumin P02768 609 Human 
F Hemoglobin subunit alpha P69905 142 Human 
F Peroxiredoxin 1 Q06830 199 Human 
F Serotransferrin P02787 698 Human 
G Cytochrome b5 P00167 134 Human 
G Carbonic anhydrase 2 P00918 260 Human 
G Lactotransferrin P02788 710 Human 
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The experiment is composed of seven runs of varying volume for each protein in a particular iTRAQ 
channel. Across the seven runs in the seven dynamic channels, each spike-in protein is present at one of 
the seven volumes exactly once. 
Table C-2 Experimental design of all seven runs for the purchased proteins. The volumes 
are in units of microlitres. 
 Protein Group 
Run Channel A B C D E F G Yeast 
1 
113 1 2 4 8 16 32 64 1 
114 2 4 8 16 32 64 1 1 
115 4 8 16 32 64 1 2 1 
116 8 16 32 64 1 2 4 1 
117 16 32 64 1 2 4 8 1 
118 32 64 1 2 4 8 16 1 
119 64 1 2 4 8 16 32 1 
121 8 8 8 8 8 8 8 1 
2 
113 2 16 1 64 4 8 32 1 
114 16 1 64 4 8 32 2 1 
115 1 64 4 8 32 2 16 1 
116 64 4 8 32 2 16 1 1 
117 4 8 32 2 16 1 64 1 
118 8 32 2 16 1 64 4 1 
119 32 2 16 1 64 4 8 1 
121 8 8 8 8 8 8 8 1 
3 
113 4 8 2 32 64 16 1 1 
114 8 2 32 64 16 1 4 1 
115 2 32 64 16 1 4 8 1 
116 32 64 16 1 4 8 2 1 
117 64 16 1 4 8 2 32 1 
118 16 1 4 8 2 32 64 1 
119 1 4 8 2 32 64 16 1 
121 8 8 8 8 8 8 8 1 
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4 
113 8 64 16 4 32 1 2 1 
114 64 16 4 32 1 2 8 1 
115 16 4 32 1 2 8 64 1 
116 4 32 1 2 8 64 16 1 
117 32 1 2 8 64 16 4 1 
118 1 2 8 64 16 4 32 1 
119 2 8 64 16 4 32 1 1 
121 8 8 8 8 8 8 8 1 
5 
113 16 32 8 2 1 64 4 1 
114 32 8 2 1 64 4 16 1 
115 8 2 1 64 4 16 32 1 
116 2 1 64 4 16 32 8 1 
117 1 64 4 16 32 8 2 1 
118 64 4 16 32 8 2 1 1 
119 4 16 32 8 2 1 64 1 
121 8 8 8 8 8 8 8 1 
6 
113 32 4 64 1 8 2 16 1 
114 4 64 1 8 2 16 32 1 
115 64 1 8 2 16 32 4 1 
116 1 8 2 16 32 4 64 1 
117 8 2 16 32 4 64 1 1 
118 2 16 32 4 64 1 8 1 
119 16 32 4 64 1 8 2 1 
121 8 8 8 8 8 8 8 1 
7 
113 64 1 32 16 2 4 8 1 
114 1 32 16 2 4 8 64 1 
115 32 16 2 4 8 64 1 1 
116 16 2 4 8 64 1 32 1 
117 2 4 8 64 1 32 16 1 
118 4 8 64 1 32 16 2 1 
119 8 64 1 32 16 2 4 1 
121 8 8 8 8 8 8 8 1 
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C.2 Exploratory Analysis of Latin Squares Dataset Characteristics  
In Section 4.4 it was stated that the missing peptide percentage between runs is low. The full table of 
percentages is presented below. For each run, the peptides found were compared to each of the six other 
runs. The percentage of peptides found in each other run was calculated by matching the peptide 
sequence, allowing for matches between two sequences if one sequence is entirely contained within the 
other. This commonly occurs when a position in a protein that could be cut by trypsin was not. For 
example, in Run 1 the peptide DSSLCK is detected, but in Run 2 only the peptide KDSSLCK is. It 
would be inappropriate to consider KDSSLCK as a missing value in Run 1 and DSSLCK as another 
missing value in Run 2. The simple explanation is that, in Run 2, the cleavage site after the K in the first 
position was missed by the enzyme. The presence of co-occurring peptides between pairs of runs was 
examined. The percentage of matched peptides between any two runs is high. 
Table C-3 Percentage of peptides in a particular run detected in another run. The 
percentage of peptides in each run that overlap with each other run is displayed. 
 Peptides Matched In Run (%) 
1 2 3 4 5 6 7 
P
ep
ti
d
e 
S
o
u
rc
e
 R
u
n
 1  89 87 89 88 86 90 
2 93  91 95 93 90 92 
3 92 92  93 92 90 93 
4 89 91 89  89 87 91 
5 91 93 92 94  90 93 
6 94 95 94 96 95  96 
7 90 87 88 91 88 88  
 
The number of proteins identified by at least one or at least three peptides was summarised for each of 
the seven experimental runs. The number of spike-in proteins is 21. The expected number of background 
proteins is unknown, but recent studies have identified more than 2000 proteins in a standard sample of 
yeast (Jung et al., 2015). 
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Table C-4. Number of proteins identified in each run. The number before the slash is for 
protein identification by at least one peptide. The number after the slash is the number of 
proteins with at least three matched peptides. 
 Proteins Identified 
Run Background Proteins Spike-in Proteins 
1 18/11 20/20 
2 16/8 20/20 
3 17/8 20/20 
4 17/9 21/20 
5 13/10 20/20 
6 14/9 20/20 
7 18/11 21/21 
 
In the explanation of performance metrics in Section 4.2, it was stated that the number of peptides 
detected for a protein increases as the length of the protein increases. The plot below demonstrates such 
a trend using the replicated Latin squares dataset. 
 
 
Figure C-1 Relationship between length of spike-in protein and number of peptides 
detected in experiment. The number of peptides associated to a spike-in protein based on 
matching by ProteinPilot’s Paragon algorithm is shown for all seven runs. 
 
C.2 Exploratory Analysis of Latin Squares Dataset Characteristics 
 
117 
Section 4.4 claimed that there is some clustering evident in a principal components plot of the 
background proteins. The figure below illustrates those patterns. The plots in the left column are 
coloured by run. In the right column, the plots colour by the iTRAQ channel. 
 
Figure C-2 Principal components analysis of background proteins. Seven yeast proteins 
were quantified in all seven runs. For each sample, the dimensionality has been reduced to 
two dimensions. Each row of plots contains yeast protein measurements summarised from 
peptides in one of the three summary methods used in this study. The first column has 
samples coloured by experimental run and the second column has samples coloured by 
iTRAQ channel.  
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C.3 Parameter Selection For Methods Comparisons 
Each of the between-sample normalisation methods has a choice of one or more parameters. Results are 
shown for the Top 3 protein summary, although the results are qualitatively the same for the other two 
summarisation options. For Simple Scaling and Two-stage Scaling, the yeast protein summary is varied. 
The maximum, sum of top 3, the median, and sum of all yeast proteins were tried. The metrics 
calculated on measurements within a sample are unchanged and not shown. Also, the metrics which sum 
across all samples are unaffected and not shown (but may be conveniently viewed with the web-based 
application). The Median summary yields the largest number of metrics closest to their ideal values. 
RUV’s performance is not robust to the value of the regularisation parameter chosen. The dependence 
was evaluated by choosing one of four ranks (𝑘 ∈ {2, 3, 4, 5}) and one of five regularisation values 
(𝜈 ∈ 10−2, 10−1, 100, 101, 102). All combinations of the two parameters were evaluated. Most 
performance metrics change noticeably for different values of the regularisation parameter but not the 
rank parameter. Larger values of the regularisation parameter have adverse effects on relative 
quantitation. 
C.4 Scaling Factor Unchanged Slope Proof  
Let 𝑥1 and 𝑥2 be two expected fold changes and  𝑦1 and 𝑦2 be experimental measurements paired with 
the x̰ measurements. Let 𝑟1and 𝑟2 be two measurements from a common reference sample used as 
denominators of the fold changes. The slope of the line between the observed and expected log-fold 
changes on the Cartesian plane, denoted by S, is: 
 
𝑆 =
log
𝑦2
𝑟2
− log
𝑦1
𝑟1
log 𝑥2 − log 𝑥1
 
and the intercept, denoted by I, is: 
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𝐼 =
log
𝑦1
𝑟1
𝑆 log 𝑥1
 
Now, consider the situation where the y̰ measurments are multiplied by a constant, 𝑐. The slope is 
𝑆𝑠𝑐𝑎𝑙𝑒𝑑 =
log
𝑐𝑦2
𝑟2
− log
𝑐𝑦1
𝑟1
log 𝑥2 − log 𝑥1
=
log 𝑐 + log
𝑦2
𝑟2
− log 𝑐 + log
𝑦1
𝑟1
log 𝑥2 − log 𝑥1
=
log
𝑦2
𝑟2
− log
𝑦1
𝑟1
log 𝑥2 − log 𝑥1
= 𝑆 
and the intercept, after scaling is: 
𝐼𝑠𝑐𝑎𝑙𝑒𝑑 =
log
𝑐𝑦1
𝑟1
𝑆 log 𝑥1
=
clog
𝑦1
𝑟1
𝑆 log 𝑥1
= 𝑐𝐼 
Therefore, the slope of the line between the points does not change, but the intercept does by a factor of 
𝑐. 
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Table C-5 Performance metrics after normalisation of Top 3 peptide summaries of 
proteins. The best value for a parameter combination is highlighted as a white metric value 
with a black background, if the difference between the lowest and highest value is at least 25% 
of the highest value. A For Simple Scaling and Two-stage Scaling considering four 
representations of the yeast proteins. B For RUV. 𝑘 is the rank parameter and 𝜈 is the 
regularisation parameter. Number shown in a cell is the mean of metrics, where there is more 
than one metric calculated. 
A  
 Yeast Proteins Summary 
Quantitation Scaling Metric Top 1 Top 3 Median All 
Absolute 
S
im
p
le
 
C.V. Median 
Proteins 0.171 0.145 0.119 0.136 
C.V. Channel Sums 
(within-run sums) 
0.776 0.850 0.856 0.814 
C.V. Channel Sums 
(between-runs sums) 
0.529 0.696 0.716 0.671 
T
w
o
-s
ta
g
e C.V. Median 
Proteins 
0.200 0.200 0.318 0.222 
C.V. Channel Sums 
(between-runs sums) 
0.537 0.711 0.710 0.673 
Relative 
S
im
p
le
 o
r 
T
w
o
-s
ta
g
e Intercept -1.190 -0.714 -0.422 -0.561 
Line Difference Sum 29.4 26.0 24.9 25.1 
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B 
 𝝂 
Quantitation Metric 𝒌 10−2 10−1 100 101 102 
Absolute 
C.V. Median 
Proteins 
2 0.288 0.261 0.216 0.165 0.137 
3 0.294 0.260 0.216 0.165 0.137 
4 0.285 0.258 0.216 0.165 0.137 
5 0.283 0.258 0.216 0.165 0.137 
C.V. Channel 
Sums 
(within-runs 
sums) 
2 0.761 0.704 0.511 0.725 0.798 
3 0.739 0.702 0.511 0.725 0.798 
4 0.727 0.700 0.510 0.725 0.798 
5 0.726 0.700 0.510 0.725 0.798 
C.V. Channel 
Sums 
(between-runs 
sums) 
2 0.732 0.674 0.366 0.238 0.250 
3 0.708 0.671 0.366 0.238 0.250 
4 0.694 0.670 0.366 0.238 0.250 
5 0.693 0.670 0.366 0.238 0.250 
Relative 
Intercept 
2 -0.057 -0.237 -1.09 -1.93 -2.10 
3 -0.073 -0.238 -1.09 -1.93 -2.10 
4 -0.082 -0.240 -1.09 -1.93 -2.10 
5 -0.074 -0.239 -1.09 -1.93 -2.10 
Line Difference 
Sum 
2 23.9 23.6 27.3 39.6 42.6 
3 23.9 23.6 27.3 39.6 42.6 
4 23.7 23.6 27.3 39.6 42.6 
5 23.7 23.6 27.3 39.6 42.6 
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